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The development of highly sophisticated technologies has ushered in the era of 
the genome. Most importantly, high-throughput sequencing technologies has vastly 
expanded the number of available genome projects of many different organisms. One of 
challenges that we now face is in understanding the information encoded within these 
genomes. Within each chapter of this dissertation, information from existing genome 
projects are used to answer fundamental biological questions related to human disease 
and an attempt to further advance new technologies is made. In chapter 2, I describe a 
novel method that decreases the error rates associated with next-generation sequencing 
technologies, allowing for the investigation of more complex and heterogenous samples 
relevant to many biological systems. In chapter 3, I use available primate genome 
projects to understand the evolutionary trajectory of two DNA repair genes, whose defect 
increases the development of breast and ovarian cancers. Finally, in chapter 4, wild-type 
primate alleles are used as tools to uncover novel mechanisms in the lifecycle of viruses. 
Although seemingly non-overlapping, each of these studies is centered around using the 
sea of information that is now readily available in order to decipher the many secrets 
encoded by genome. 
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Chapter 1: Introduction to Dissertation 
I have been blessed with a unique opportunity to work on several very different 
projects during my graduate studies. As such, each project deserves its own introduction 
and is therefore included at the start of every chapter. In the place of a formal 
introductory chapter, extended abstracts for each project are presented below. 
 
CIRCLE-SEQUENCING: A NEW ERROR-CORRECTING METHOD FOR HIGH-THROUGHPUT 
SEQUENCING DATA 
Unlike traditional Sanger sequencing machines that can only determine several 
hundred sequences at a time, high-throughput sequencing technologies are able to 
simultaneously sequence millions of different DNA molecules from complex mixtures. 
These machines have revolutionized the study of biological systems by offering vastly 
increased throughput and by dramatically reducing costs (1, 2). For example, if one were 
to sequence all 3 billion bases of the human genome, it would take at least 3.75 million 
reactions and cost $7.2 million using Sanger sequencing. With next-generation 
sequencing, one run can potentially sequence the entire human genome for only $6000 
(3). Therefore, it is no wonder that scientists have heavily utilized these technologies in 
the recent years to address outstanding research problems and to ask provocative new 
questions.  
However, a fundamental problem with all next generation sequencing 
technologies is that there is a relatively high rate of incorrectly identified DNA bases 
(typically on the order of 1%) (1). This problem can partially be overcome in cases where 
a homogenous sample, such as the genomic DNA of one individual, is sequenced by 
simply reading every base at least 30 times. By doing so, several errors generated by the 
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machine can be identified and eliminated. Unfortunately, this solution is not completely 
effective at eliminating sequencing-generated errors and is not applicable for 
heterogeneous samples, like tumors, where one wishes to actually identify genetic 
variants. For this reason, the error rate problem renders these new technologies unable to 
address many of the important problems in biomedical research.  
Several attempts have been made to address the error rate problem. These 
methods primarily involve covalently attaching a unique identifying sequence, also 
referred to as barcodes, to individual DNA molecules (4-8). The barcoded samples are 
then amplified using a DNA polymerase to generate multiple copies of each sequence. By 
doing so, each molecule of DNA can be read several times and a consensus sequence can 
be derived.  While these methods can achieve impressively low error rates, this is an 
extremely inefficient process. First, the ligation of barcodes to the DNA molecules is 
very inefficient and this excludes a majority of the sample from being sequenced. In 
addition, the number of copies that are generated during PCR is extremely difficult to 
control, often times leading to under- or over-amplification of the sample. Lastly, the cost 
associated with optimizing the conditions described above can be inhibitory, especially 
when sequencing large genomes.   
To circumvent these issues, we have developed a unique library preparation 
strategy and accompanying computational correction scheme called circle sequencing, 
described in Chapter 2. In this method, copies of individual DNA templates are 
circularized and copied multiple times in tandem with a rolling circle polymerase, 
resulting in physically linking of each copy. These products are then sequenced on any 
high-throughput sequencing machine. Each read produced is computationally processed 
to obtain a consensus sequence of all linked copies of the original molecule. Because the 
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circle-sequencing protocol precedes standard library preparations, it is suitable for a 
broad range of sequencing applications.  
 
RAPID EVOLUTION OF THE DNA REPAIR GENES BRCA1 AND BRCA2 
The maintenance of chromosomal integrity is an essential task of every living 
organism and cellular repair mechanisms exist to guard against insults to DNA. Because 
the genome encodes all the information needed to sustain life, it is imperative that DNA 
repair mechanisms exist to recognize and fix damages to the DNA. This is exemplified 
by the fact that mutations in genes that are involved in DNA repair often lead to 
devastating diseases or are associated with an increased risk for cancer (9).  
The most detrimental type of DNA damage is the double strand break (DSB). 
Immediately after the induction of a DSB, an elaborate cascade of signaling events 
occurs, resulting in the initiation of the DNA damage response (9). The DNA damage 
response primes the nuclear environment in preparation for the repair of these lethal 
lesions by activating the appropriate signaling molecules, recruiting essential DNA repair 
factors, and halting the progression of the cell cycle to allow time for efficient repair. In 
humans, two major repair mechanisms are devoted to the repair of DSBs: the non-
homologous end-joining (NHEJ) and the homologous recombination (HR) pathways 
(10). Classically, the NHEJ pathway is considered to be an error-prone process in which 
the two ends of the broken chromosome can undergo resection and direct ligation, 
resulting in mutagenic deletions or insertions at the site of damage. This process of DSB 
repair predominates during most phases of the cell cycle because it does not require a 
sister chromatid to serve as a template for repair. The homologous recombination 
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pathway, on the other hand, utilizes a template for perfect repair and is most active during 
the S and G2 phases of the cell cycle.  
Given the importance of these processes, it is expected that proteins involved in 
the DNA damage response and repair pathways would be evolutionarily conserved, 
exhibiting very minimal sequence change over time. However, several DNA repair 
proteins have been shown to be evolving rapidly, accumulating mutations at a rate that is 
much higher than expected by chance (11, 12). In particular, BRCA1, an essential gene 
whose protein product plays several roles in DDR and repair, exhibits a striking signature 
of rapid evolution that is characteristic of a gene under intense selective pressure (12-17). 
Although these studies have been enlightening, sequences from very diverse mammals 
were utilized. This can be especially problematic when identifying specific residues 
undergoing rapid evolution because different selective forces may have uniquely acted 
upon different mammalian species. To better understand the pressures that the BRCA1 
gene has faced in humans and non-human primates, an evolutionary analysis using a 
more extensive dataset that includes a number of closely related primate species is ideal.  
In chapter 3, we explore the evolutionary history of BRCA1 and BRCA2, another 
hereditary determinant of breast and ovarian cancers, in primates. We show that specific 
residues in the primate BRCA1 and BRCA2 proteins are evolving rapidly and that these 
residues are different than the ones previously reported in the literature. We also find 
considerable variation within primate populations and provide evidence for recent 
selection in chimpanzee populations. We put forth a hypothesis in which pathogens may 
be driving the evolution of these essential genes. 
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THE DNA REPAIR PROTEIN NBS1 IS A BARRIER TO HSV-1 REPLICATION 
On October 22nd, 1932, Dr. W.B suffered a bite from a rhesus macaque during the 
course of an experiment. He treated his own wound with simple first aid measures and 
continued on with his study. A few days later, the superficial lesion became noticeably 
red and swollen, eliciting pain in the patient. He was admitted to the hospital shortly 
thereafter, with a low-grade fever and swelling of the affected arm. As his condition 
began to improve, small fluid-filled vesicles began to form at the site of penetration. 
However, several days after the incident, the patient began to show signs of rapid 
neurological deterioration and eventually succumbed to his death (18, 19).  
The pathological agent responsible for the patient’s demise was found to be the 
macaque simplex virus 1 (MHV-1), also known as herpes B virus. Much like herpes 
simplex virus 1 (HSV-1) of humans, MHV-1 is a ubiquitous virus in the macaque 
population that establishes a lifelong infection with periodic reactivation (20). Active 
viral shedding is usually asymptomatic in macaques, but can result in the same types of 
oral and ocular lesions induced by HSV-1 in humans. So how is it that MHV-1 causes 
such a devastating disease in humans while showing no signs of presence in its original 
host? The answer lies within the genome of the virus and the organism that it infects.  
Viruses encode for a number of proteins that facilitate replication within a cell, 
many of which establish interactions with host proteins that further enhance the viral 
lifecycle. In cases where virus-host interactions are sub-optimal, viral replication may be 
considerably crippled or even non-existent. Conversely, when these interactions are too 
strong, uncontrolled amplification of the virus may cause serious harm to the host, 
resulting in death. Both of these scenarios represent a dead-end for the virus, resulting in 
a barrier to successful and sustained cross-species transmission of the virus. Therefore, it 
is within the best interest of the virus to accumulate advantageous mutations and fine-
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tune these interactions to strike a balance these two outcomes, a process called viral 
adaptation. Even after the virus has adapted to its host, the virus may continue to evolve 
in an effort to be maintained within the host, in a similar dynamic to that described above 
called codivergence.  
Genetic similarities between a host and a closely related non-host species can 
facilitate the introduction of a virus to a new species. In fact, the human population is 
constantly plagued by the emergence of new viral threats resulting from transmission 
events that cross species boundaries (21, 22). One classical example is that of the human 
immunodeficiency viruses (HIV), a result of simian virus transmission from primates to 
humans. Although simian immunodeficiency viruses (SIVs) cause little to no disease in 
their natural primate hosts, HIV infection in humans results in a progressive decline in 
CD4+ T-cells that eventually leads to immunodeficiency. This disparity in clinical 
outcomes could be a result of inadequate adaptation of HIV in the genetically similar, but 
not identical, human host. This newly forged relationship between virus and host has yet 
to strike the balance seen in codivergence.  
As such, it is of considerable interest to understand the complex network of host-
virus interactions so that one day, we may be able to predict the potential virulence of 
“new” viruses that threaten the human population (23). In chapter 4, we investigate the 
dynamic interaction between HSV-1 and the host DNA repair protein, Nbs1. We show 
that HSV-1 hijacks Nbs1 functions in a species-specific manner in order to augment the 
viral lifecycle. We identify a primate Nbs1 allele that is resistant to recruitment by HSV-
1 and show that this variant may pose a significant barrier to infection by the virus. 
Further studies are warranted to determine if other primate simplex viruses are able to 
utilize the human Nbs1 protein for advancing the viral lifecycle. These types of analyses 
should be extended to other cellular factors that can potentially restrict or aid in the viral 
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lifecycle of herpes simplex viruses so that we can gain a better understanding of this 
particular host-virus interaction landscape. This will allow us to predict the pathogenic 
potential of these viruses if and when they gain a foothold in the human population. 
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Chapter 2: High-throughput DNA sequencing errors are reduced by 
orders of magnitude using circle sequencing 
 
INTRODUCTION 
High-throughput DNA sequencing has emerged as a revolutionary force in the 
study of biological systems. However, a fundamental limitation of these technologies is 
the high rate of incorrectly identified DNA bases in the data produced (1, 2). For 
instance, reports in the literature suggest that Illumina sequencing machines produce 
errors at a rate of ∼0.1–1 x 10−2 per base sequenced, depending on the data-filtering 
scheme used (1, 24). These technologies typically produce billions of base calls per 
experiment, translating to millions of errors. When sequencing a genetically homogenous 
sample, the effects of erroneous base calls can be largely mitigated by establishing a 
consensus sequence from high-coverage sequencing reads. However, even high coverage 
does not eliminate all errors, and attempted verification of detected variants has often 
revealed the vast majority to be sequencing errors (for example, see refs. (25, 26)). 
Furthermore, the depth of coverage required for consensus building remains cost-
prohibitive for large genomes such as the human genome. As a result, most human 
studies involving high-throughput sequencing have been limited to only a small fraction 
of the genetic information, such as the transcriptome, mitochondrial DNA, or a single 
chromosome. In contexts where rare genetic variants are sought, this error-rate problem 
presents an even more profound barrier. Examples of rare variant problems include the 
analysis of mutations in genetically heterogeneous tumors, identification of drug-
resistance mutations in microbial populations, and characterizations in immunogenetics 
(such as B- and T-cell profiling). The mutations of interest in these types of samples may 
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be present at low frequencies, potentially even lower than the sequencing error rate itself. 
Here, the problem cannot be overcome with high sequence coverage because a consensus 
sequence of the heterogeneous sample will mask all variants. 
To address this error rate problem, several closely related library preparation 
protocols have recently been described (4-8). A general schematic for these “barcoding” 
strategies is shown in Figure 2-1. Each individual DNA molecule in the input material is 
marked by the ligation of a uniquely identifiable sequence, or barcode (step 1). Barcoded 
products are then amplified by PCR (step 2), and the amplified pool is sequenced (step 
3). Barcode identity is then used to computationally organize sequencing reads into “read 
families,” where each read family consists of all downstream derivatives of a single 
starting molecule (step 4). A consensus sequence is then derived from the reads in each 
family, with a typical criterion being that the read family must contain at least three 
members before a consensus sequence is derived (4, 7). 
Although barcoding strategies successfully lower the sequencing error rate, these 
methods have both theoretical and practical limitations that affect the accuracy and cost 
with which consensus sequences can be produced. First, the members of a read family are 
not independent copies of the original molecule. Errors that arise during the early stages 
of PCR, known as jackpot mutations, are amplified exponentially and can appear multiple 
times in a read family. Second, some templates may be amplified more or less efficiently 
due to differences in either the barcodes or the target sequences themselves (4). This bias, 
along with unavoidable variance in the sampling process, results in many read families 
being much larger or smaller than necessary, reducing efficiency. Third, if identical 
barcode sequences are ligated to multiple input molecules similar in sequence, incorrect 
assembly of read families can occur. This issue is especially problematic when 
sequencing highly similar molecules such as in amplicon libraries. Finally, sequencing 
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errors introduced into barcodes themselves contribute to inefficient formation of read 
families. 
 
 
Figure 2-1: Overview of traditional barcoding methods. In traditional barcoding 
methods, adapters containing randomized nucleotide regions (barcodes) are ligated to 
each molecule in the DNA sample (step 1). The library is then amplified by PCR (step 2). 
Products are sequenced on the high-throughput sequencing platform of choice (step 3). 
Individual reads containing the same barcode are grouped into read families (gray boxes), 
and consensus sequences are derived (step 4). Errors generated during PCR amplification 
(step 2, blue circles) and during the sequencing process (step 3, blue circles) are removed 
bioinformatically. 
In theory, all of these problems could be avoided if each read family were 
packaged and delivered as a single molecule, bypassing the need for barcodes to 
construct read families. Continued advances in the read lengths of major sequencing 
platforms have made such an approach possible. We have developed a unique library 
preparation method that (i) eliminates the use of barcodes, (ii) eliminates the effects of 
jackpot mutations by amplifying DNA templates in a way that does not propagate errors 
within read families, and (iii) physically links the repeated information comprising each 
read family so that it comes out of the sequencing process in the optimal proportions 
needed for efficient error correction. We show that our method produces high- 
throughput sequencing data with errors at only 8–10 x 10−6 of base positions sequenced 
and has an efficiency that is vastly improved over existing barcoding schemes. Our 
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library preparation method, called “circle sequencing,” fits into existing high-throughput 
sequencing workflows, making it immediately available for a broad range of applications. 
 
MATERIALS AND METHODS 
Circle sequencing 
Genomic DNA was extracted from the S. cerevesiae strain S288C, sheared, run 
on a 1.5% low-melting-point agarose gel, and a narrow slice corresponding to 150 bp was 
extracted. DNA was phosphorylated and denatured. 300 ng DNA (∼3 pmol) was 
circularized per 20 μL reaction using CircLigase II ssDNA ligase (EpiCentre), and 
uncircularized DNA was removed with exonuclease. Exonuclease-resistant random 
primers and varying amounts of DNA circles were annealed and added to the rolling 
circle reaction consisting of reaction buffer, dNTPs, BSA, inorganic pyrophosphatase, 
uracil-DNA glycosylase, formamidopyrimidine-DNA glycosylase, and Phi29 DNA 
polymerase. For a detailed protocol, refer to Appendix A. Barcoded samples were 
prepared as in ref. (7). 
 
Bioinformatic Processing 
Our computational pipeline processes circle-sequencing data generated by paired-
end reads. The structure of the tandem copies within each read pair is determined by 
detecting periodicity in each sequence and by aligning the pair of sequences to each 
other. A consensus sequence is then derived from the copies produced in combination 
with the base quality scores assigned to each. The junction of circularization in each 
consensus sequence is identified by performing a rotation-insensitive mapping of the 
consensus sequence to a reference genome. See ref. (27) for a detailed description. 
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RESULTS 
Circle Sequencing: Library Preparation 
Our library-preparation method, circle sequencing, is illustrated in Figure 2-2. 
The input material for this protocol can be chromosomal DNA, cDNA, amplicons, or any 
other DNA. The material is size-selected (through amplicon design, shearing followed by 
gel purification, etc.) such that the size of each fragment averages around 1/3 the 
anticipated read length from the high-throughput sequencing machine being used. 
Double-stranded DNA fragments are denatured and the resulting single-stranded DNA is 
circularized (step 1). Non-circularized products are eliminated by exonuclease digestion. 
Random primers are then annealed to the single-stranded circular DNA, and 
amplification is performed using the Phi29 polymerase. This polymerase possesses 
single-strand displacement activity that allows it to replicate continuously around the 
ligated circle, referred to as rolling circle amplification (step 2). The random primers also 
anneal to the newly synthesized single-stranded product and allow it to be converted into 
double-stranded DNA. The resulting double-stranded DNA products (step 2, lower) are 
concatamers consisting of multiple tandem copies (brackets) of the information in the 
original fragment. These products are sequenced (step 3), and the information in the 
tandem copies is used to form a read family and a consensus sequence (step 4). Any 
genetic variant that existed in the input material (red circle) will be present in all tandem 
copies whereas errors introduced by the Phi29 polymerase (blue circles in step 2) or by 
the sequencing process (blue circles in step 3) will occur independently and randomly 
throughout the template. 
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Figure 2-2: Overview of circle sequencing. In circle sequencing, DNA is denatured and 
single-stranded DNA is circularized (step 1). Random primers are annealed to circles, and 
Phi29 polymerase is used to perform rolling circle replication (step 2). This polymerase 
has strand-displacement activity so products contain tandemly linked copies of the 
information in the circle. Random primers and Phi29 polymerase turn long single-
stranded copies into double-stranded DNA (step 2, lower). The tandem copies of 
information are sequenced using any high-throughput sequencing technology (step 3). 
Here, a single long read is shown for simplicity although paired-end reads were used in 
this study. Each read (or paired-end read pair) is then computationally split into the 
individual copies of the original circle, grouped into a read family (gray box), and used to 
generate a consensus sequence (step 4). 
The rolling circle products generated in circle sequencing can theoretically be 
sequenced on any high-throughput sequencing platform that offers read lengths long 
enough to observe multiple repeats within the same product. Illumina technologies 
currently offer the highest throughput and cost-efficiency, with read lengths of up to 500 
bases possible on the MiSeq platform using 2 x 250 paired-end reads. Our bioinformatic 
pipeline processes circle-sequencing data generated by paired-end reads. This pipeline 
identifies the repeating units of the original information in each read pair. It then uses 
these repeats, combined with base call quality scores, to derive a consensus sequence 
along with a consensus quality score for each consensus base. The pipeline also maps 
these consensus sequences to a reference genome. 
One advantage of circle sequencing is that it is largely resistant to the effects of 
jackpot mutations that can occur in PCR. Errors will also be made during rolling circle 
amplification, but will not propagate within a read family because each linked copy is in- 
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dependently derived from the original molecule (Figure 2-3). An upstream PCR 
amplification step may be required for some applications of circle sequencing (e.g., for 
cDNA or amplicon libraries). Circle sequencing will not be able to mitigate the effects of 
jackpot mutations accumulated before templates are circularized. In such cases, care 
should be taken to minimize amplification cycles upstream of the circle-sequencing 
pipeline. Alternately, circle sequencing can also be applied directly to RNA templates 
(28). 
 
Figure 2-3: Error propagation in read families. In circle sequencing, Phi29 
polymerase primes off of a random primer (orange) to generate a single copy of the 
circular template. After the polymerase completes the first copy (black), it displaces that 
strand and begins a second copy (shown in pink), then a third copy (shown in green), and 
so on. Errors incorporated by the polymerase during the replication of the first repeat 
(green dot) will only be contained within the first repeat (black) and not in subsequent 
repeats (pink, green, yellow).  
 
Error Rate of Circle Sequencing 
To measure the error rate of this method, we sequenced the ∼12-megabase 
Saccharomyces cerevisiae genome. First, we used standard Illumina MiSeq sequencing to 
obtain 51X coverage of a haploid S288C strain. We identified 514 positions at which 
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there is strong evidence that the genome sequence of this strain differs from the published 
reference S288C sequence. Bases mapping to these questionable sites, or to repetitive 
sequences, were subsequently ignored throughout this study. Next, we sequenced the 
strain with circle sequencing and mapped the resulting consensus sequences to the 
reference genome. Error rates were calculated as the fraction of consensus bases that 
differed from the reference sequence. As a proof of concept that the circle-sequencing 
process is capable of eliminating sequencing errors, we calculated the error rates of 
consensus sequences formed by incrementally incorporating each repeat contained in 
each read pair. High-quality bases in the first repeat of each sequencing read had an error 
rate of 5.8 x 10−4 (Figure 2-4A). As expected, this error rate fell as the tandem repeats 
were used to correct the error in the first repeat. However, the effect was surprisingly 
small. The inclusion of subsequent tandem copies in our reads reduced this error rate only 
to 2.9 x 10−4 with two repeats and 2.7 x 10−4 with three repeats (Figure 2-4A). Because 
the circularized fragments used in the circle-sequencing pipeline are size-selected, but 
still vary in size according to a distribution, we recover four and sometimes more repeat 
units in some of the read pairs. The addition of subsequent repeats beyond three did not 
lower the error rate further, and the asymptotic value of the error rate achieved (2.8 x 
10−4) was not as small as would be implied by the informational redundancy obtained. 
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Figure 2-4: Circle sequencing decreases the error rate of high-throughput 
sequencing. (A) Shown is the error rate of circle sequencing upon incorporation of 
additional copies of the tandemly duplicated information. When just the first repeat is 
considered, only bases with quality scores greater than or equal to 30 are used. (B) The 
profile of the types of errors in circle sequencing consensus sequences (blue bars) reveals 
a striking signature dominated by G-to-A and C-to-T errors, consistent with base damage 
due to cytosine deamination. The addition of uracil-DNA glycosylase and 
formamidopyrimidine-DNA glycosylase during rolling circle amplification (green bars) 
dramatically eliminates the majority of errors (red) caused by DNA damage of the types 
targeted by these enzymes. The lower range is shown in more detail in the Inset. (C) As 
in A, the graph shows the error rate of circle sequencing upon incorporation of additional 
copies of the tandemly duplicated information, after the protocol was modified to include 
DNA repair enzymes. 
One barrier to achieving lower error rates using circle sequencing could be DNA 
damage incurred by sequencing templates during the library preparation protocol. This 
damage would be especially problematic because, unlike random mutations introduced 
by the polymerase, a damaged base within the original circular template might be paired 
with the same incorrect base each time the polymerase replicates around the circle. This 
process would lead to the propagation of an error in all tandem copies of the circular 
information. These errors would then be seen as high-confidence base calls and 
effectively increase the overall error rate. In fact, DNA damage has been identified as a 
major source of error in standard barcoding-based approaches (7). To examine this 
possibility further, we analyzed the different types of erroneous base calls produced in 
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circle-sequencing consensus sequences (Figure 2-4B). Interestingly, we discovered that a 
large proportion of mismatches between the consensus sequences and the reference 
genome were G-to-A and C-to-T mutations. These types of mutations occur when a 
cytosine base undergoes spontaneous deamination to form uracil. Adenine is incorporated 
opposite of the uracil during synthesis of the complementary strand, propagating G-to-A 
and C-to-T transitions. We did not detect a substantial number of G-to-T and C-to-A 
mismatches indicative of oxidized guanine bases (8-oxo-guanine), the other common 
type of damage found to affect barcoded samples (7). 
Deaminated cytosine and 8-oxo-guanine bases can be excised using the 
commercially available enzymes uracil-DNA glycosylase (UDG) and 
formamidopyrimidine-DNA glycosylase (Fpg). To test whether these specific types of 
damaged bases negatively affect the error rate of our method, these enzymes were 
included during the rolling circle amplification step. As shown in Figure 2-4B, their 
addition almost completely eliminated damage-induced errors (green bars). We speculate 
that circular templates that undergo the removal of these damaged bases are precluded 
from serving as substrates for Phi29 polymerase. We found that treatment of genomic 
DNA with UDG and Fpg before proceeding with conventional MiSeq library preparation 
resulted in no change in the mutation profile, suggesting that this damage to DNA is 
actually incurred during the circle-sequencing library preparation. After modifying our 
protocol to include these repair enzymes, we reexamined the impact of analyzing one, 
two, three, and four repeats in consensus building (Figure 2-4C). The inclusion of up to 
four repeats substantially improved the overall error rate from 2.8 x 10−4 (without 
enzymes) to 7.6 x 10−6 (with enzymes). Thus, the error-correcting power of circle 
sequencing is clear, but care must be taken to address damaged bases that arise during the 
preparation of these special libraries. It is interesting to note that the extent of DNA 
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damage present in DNA mixtures, and the resultant calling of erroneous bases during 
downstream sequencing, is only now becoming evident due to the extremely low error 
rates being achieved by our and other sequencing methods (7). We anticipate that 
accurate, high-throughput sequencing will provide increased resolution into many types 
of biological phenomena. 
 
Efficiency of Circle Sequencing and Barcoding 
An important metric to consider when selecting an error-correction scheme (i.e., 
barcoding versus circle sequencing) is cost. Cost is directly related to the efficiency of 
these methods in turning low-quality data into high-quality data. A major determinant of 
the overall amount of high-quality data produced by a method is how efficiently the 
method distributes raw sequencing data across all of the read families produced. The 
existence of read families that do not contain enough members to produce a consensus, or 
read families that contain substantially more members than necessary, represents wasted 
sequencing resources. To analyze this aspect, we define efficiency as the ratio of 
consensus bases produced to the total number of bases used to produce them. As 
described above, read families must have at least three members to build consensus 
sequences. If all read families consist of exactly three members, a perfect efficiency of 
33% would be achieved. For circle sequencing, the size of read families is dictated by the 
lengths of the circularized molecules. To achieve perfect efficiency of 33%, input 
molecules must be exactly 1/3 the read length. However, any practical size-selection 
scheme will produce molecules with a distribution of sizes around this desired length. 
This distribution, and the use of paired end reads (discussed later in this section), results 
in the actual achieved efficiency being slightly lower than the ideal. In agreement with 
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this reasoning, we achieved an efficiency of 20.2% for circle sequencing (Figure 2-5A). 
One consensus base is produced for every five bases used to build read families. 
For comparison, we calculated the efficiency of consensus sequence formation 
with barcoding using a dataset from a previously published study by Schmitt et al. (7). 
This barcoded dataset, derived from the M13mp2 phage genome, produced consensus 
sequences with an efficiency of 3.0% (Figure 2-5A). One consensus base is produced for 
every 33 bases analyzed. This efficiency is similar to previously reported barcoding 
efficiencies, which range from 1–8% (4, 5, 7). In this particular dataset, the authors used 
a sophisticated barcoding scheme called duplex barcoding. Here, the forward and reverse 
strands of each double- stranded input molecule are asymmetrically labeled with 
barcodes, allowing for the acquisition of either standard barcoding read families or, 
alternately, more elaborate read families consisting of at least three reads from each 
strand (i.e., at least six reads total). As would be expected because of the heightened read 
family criteria, duplex-barcoding consensus sequences were formed with an efficiency of 
only 0.8% with this dataset, substantially less than the efficiencies of either circle 
sequencing or standard barcoding. 
For barcoding-based approaches, efficiency is dictated by the ratio of barcoded 
input molecules to total reads produced. If there are too many uniquely barcoded 
molecules relative to the number of reads produced, read families will tend to be too 
small for the formation of consensus sequences. Alternately, if there are too few uniquely 
barcoded molecules relative to the reads produced, read families will be much larger than 
they need to be, wasting reads. To explore this dependence further, we applied duplex 
barcodes to sheared yeast genomic DNA and used five different concentrations of input 
molecules for amplification. Each sample was amplified under identical conditions and 
sequenced, with the same number of total sequencing reads requested for each. We 
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measured the efficiency with which standard barcoding and duplex barcoding consensus 
sequences were formed across the five datasets (Figure 2-5B). For both standard and 
duplex barcoding, the efficiency rose, peaked, and declined within the range of library 
sizes used. The efficiency peaked at a very small library size of 4 attomol for both 
standard barcoding and duplex barcoding (7.8% and 1.3%, respectively). Although 
concentration of input DNA is easy to control in setting up these reactions, the optimal 
library size depends on both barcoding efficiency and the number of reads actually 
produced in the final dataset. Therefore, the initial input library size must be empirically 
determined for each experiment. 
 
 
Figure 2-5: Efficiency of circle sequencing and barcoding methods. (A) The table 
shows key metrics of efficiency for the three approaches discussed: circle sequencing, 
standard barcoding, and duplex barcoding. “Bases in” refers to the total number of bases 
used to build read families. For the barcoding-based approaches, these are bases in well-
formed, uniquely mapping reads. For circle sequencing, these are bases in reads showing 
clear periodicity. “Bases out” refers to consensus bases. Consensus bases are produced 
from read families with at least three members (at least three members derived from each 
strand for duplex barcoding). Efficiency is calculated as the number of consensus bases 
produced divided by the total number of bases used to produce them (“bases out” divided 
by “bases in”). Standard and duplex barcoding values (S superscript) are derived from a 
dataset from ref. (7), which was reanalyzed here. (B) Standard barcoding and duplex 
barcoding were used to sequence yeast genomic DNA. Tenfold serial dilutions of the 
input material were made before the library amplification step and an 18-cycle PCR was 
performed. The number of eligible reads refers to the number of reads used to build read 
families. Also shown are the number of read families consisting of at least three members 
(standard barcoding) or at least three members from each strand (duplex barcoding), and 
the efficiency of consensus sequence formation (ratio of read families produced to total 
eligible reads).  
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Next, we looked at the distribution of sizes of read families for the two dilutions 
producing the highest efficiency (40 and 4 attomol) (Figure 2-5B). These datasets 
produced 18,020 and 29,036 read families with 3 or more members (Figure 2-5B). In the 
40 attomol library, most read families contained only one or two members (Figure 2-6). 
In the 4 attomol library, most read families have many more than 3 members, with the 
average read family size being ∼12 (Figure 2-6). These results clearly demonstrate a 
direct correlation between input concentration and efficient use of sequencing reads to 
produce consensus sequences. 
 
 
Figure 2-6: Read family sizes in the standard barcoding method. The distribution of 
sizes of read families (number of reads per read family) produced by standard barcoding 
with 40 attomol input (blue) and 4 attomol input (green).  
To determine the precise expected relationship between input library size and 
efficiency beyond the five experimental points sampled, we analyzed an idealized 
theoretical model of the barcoding process. In this model, every barcoded input molecule 
is massively and uniformly amplified so that each sequencing read produced has an equal 
and independent chance to sample each of the original input molecules. For simplicity, 
we assume that exactly 1 million usable sequencing reads are always produced. The 
expected efficiencies of recovering input molecules at least three times for standard 
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barcoding (Figure 2-7, purple) and recovering both strands of input molecules at least 
three times each for duplex barcoding (Figure 2-7, green) are plotted as a function of the 
number of uniquely barcoded input molecules. As discussed above, the idealized perfect 
efficiency for these approaches would be 33% (or half of this for duplex barcoding). 
However, unavoidable variance in the distribution of read-family sizes due to the random 
sampling process caps the efficiency of standard barcoding at 19% and duplex barcoding 
at 8%. Perhaps more notable is the rapid decline in efficiency observed when the number 
of barcoded input molecules falls outside a narrow range around these peaks. In practice, 
precise control over the ratio of barcoded molecules to usable sequencing reads can be 
difficult to achieve. For instance, inferred estimates of the fraction of input molecules that 
had barcodes successfully ligated to them varied by a factor of 1.7 across the experiments 
that we analyzed (Table 2-1). There is also substantial run-to-run variability in 
sequencing machine output and in the number of reads wasted on undesired products 
such as adapter dimers or ill-formed barcodes. In summary, barcoding-based efficiencies 
are difficult to control and capped at an absolute upper bound of 19%. 
 
 
Figure 2-7: Predicted circle sequencing efficiency is independent of library size. 
Theoretical efficiency of consensus sequence formation from 1,000,000 sequencing reads 
using standard barcoding (purple), duplex barcoding (green), and circle sequencing 
(orange) as a function of the number of unique molecules in the input library. 
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Table 2-1: Efficiencies of barcode ligation. 
We next examined the theoretical efficiency of circle sequencing. The expected 
efficiency for 150-base circular templates sequenced using 2 x 250 base reads is 27% 
(Figure 2-7). This number is less than the predicted efficiency of 33% because paired end 
reads are used. Because rolling circle amplification products are sheared randomly and 
read from either end, each read from a read pair will begin at a different base position 
within the repeated sequence. This offset introduces some variability in the number of 
repeats in a read family, with not all repeats being full length (illustrated in Figure 2-2, 
step 4). Importantly, however, because the repeats within a read family are physically 
linked and do not need to be recovered from a bulk mixture by sampling, efficiency will 
not vary with the number of molecules in the input library. Efficiency is therefore a flat 
line across all input library sizes. This plot demonstrates two key features of circle 
sequencing: the theoretical peak efficiency is higher than for barcoding-based 
approaches, and this efficiency is insensitive to experimental conditions, sidestepping a 
major liability of barcoding-based approaches. 
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Table 2-2: Yield and error rates of libraries analyzed. 
Although the efficiency of consensus sequence formation is critically important, a 
wide range of other practical issues also affects the total amount of usable data produced. 
We define yield as the total number of high-quality consensus bases produced divided by 
the raw number of sequenced bases before any filtering or data processing is performed. 
This metric considers the overall loss of data in a sequencing project from start to finish, 
including not only loss due to consensus formation, but also losses due to data filtering 
and trimming schemes and reads that can’t be mapped uniquely to the genome being 
sequenced. Based on this final point, the parameter of yield will therefore be somewhat 
genome-specific, as repetitive information and missing regions in genome assemblies can 
vary from genome to genome. To quantify the cumulative impact of all of these effects 
on the yield of error correcting methods, we used circle sequencing to sequence a set of 
yeast genomic libraries that varied in input concentration and/or total reads produced, and 
compared the data with the set of yeast genomic libraries sequenced with barcoding. The 
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input molecules used and the total sequencing reads obtained for each sample are 
summarized in Table 2-2. 
Figure 2-8 shows four standard barcoding samples and five circle-sequencing 
samples on a plot of yield versus error rate. All five of the circle-sequencing samples, 
regardless of molecules in the original library or reads produced, had a yield and an error 
rate that clustered within a tight range (orange points). The barcoding libraries were more 
disperse on this plot, with the samples varying significantly in both yield and error rate 
(green points). Even the most efficient barcoding samples (4 attomol and 40 attomol 
libraries) had a yield that was only 1/3 that of the circle-sequencing samples, equating to 
a cost that would be three times as high for the same amount of high-quality, error- 
corrected data. 
Although yields obtained in experiments targeting genomes of different 
complexities are not directly comparable for the reasons discussed above, we also include 
values for the barcoded M13mp2 phage genome dataset, which was produced with the 
Illumina HiSeq machine (7). We find that the metrics of yield and error rate are similar 
despite differences in the genomes sequenced and sequencing platform used (Figure 2-8, 
gray points). The method that currently produces the lowest error rate is the duplex 
barcoding method of Schmitt et al. (7). However, the yield of this method is very low, 
with ∼1 out of 1,000 bases sequenced being recovered as a consensus base. For all 
sequencing projects, high yield and low error rate are desirable, and so the best methods 
will fall in the upper right hand corner of the plot in Figure 2-8 (purple arrows). Circle 
sequencing produces high yield and low error rate and is highly robust to experimental 
design in ways that barcoding approaches are not. 
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Figure 2-8: Comparison of overall yield and error rate for all error-correction 
methods. The yeast genome was sequenced with standard barcoding (green points) or 
circle sequencing (orange points) while varying input DNA concentration and/or reads 
produced. Error rate (x axis) is defined as the fraction of consensus bases that differ from 
the reference sequence. Yield (y axis) is the total number of consensus bases produced 
divided by the raw number of bases sequenced. Circle sequencing produces consistent 
error rates and yields across a range of experimental conditions (orange shading). 
Standard barcoding produces highly variable error rates and yields. Another library 
discussed in the text, from the M13mp2 phage genome generated in ref. (7), was also 
analyzed (gray points). 
Finally, we considered whether sequence-specific biases affect our library 
preparation, such as bias in template circularization. This bias could result in non-uniform 
coverage of the genome being sequenced. As might be expected, we did observe that 
some degree of template bias is introduced by both barcoding and circle sequencing when 
each is compared with standard Illumina sequencing. This effect was slightly larger for 
circle sequencing although the skews in coverage were not extreme in either case (Figure 
2-9). We also considered that some circular templates might have sequence features that 
lead to biased amplification during library preparation. This bias could result in many 
reads deriving from the same circular template. However, we found that greater than 
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98.8% of the consensus sequences produced in each dataset were derived from unique 
circular templates, and no single circular template produced more than five consensus 
sequences. 
 
 
Figure 2-9: Genome coverage obtained with three different sequencing methods. A 
comparison of genome coverage is made between conventional MiSeq data (blue line), 
circle-sequencing data (green line), and standard barcoding data (red line). Here, we 
analyzed the observed fraction of all positions in the yeast genome (y axis) as a function 
of the number of processed bases used (x axis). Uniquely mapping reads (conventional) 
or uniquely mapping consensus sequences (circle sequencing and standard barcoding) 
were shuffled and then processed one-by-one while recording the fraction of all positions 
in the yeast genome covered at least once. To control for the influence of sequence 
lengths on mappability, conventional reads and barcoding consensus sequences were 
trimmed to exactly match the empirical distribution of circular consensus sequence 
lengths. The gap between the blue and green lines indicates that the enzymatic steps 
involved in circle sequencing introduce some degree of bias in which regions of the 
genome tend to be observed, but that the effect is not extreme. The difference in fraction 
of genomic positions covered (y axis) between the blue and green lines is never more 
than 11.5% (meaning that. for a given number of sequencing bases used, conventional 
sequencing has covered at most 11.5% more genomic positions than has circle 
sequencing). The barcoding line (red) terminates early because the barcoding process 
produced substantially less consensus sequence data. 
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DISCUSSION 
Circle sequencing is a library preparation method for high-throughput sequencing 
that achieves low error rate and high efficiency. Its biggest strength is that it is efficient 
over a range of experimental designs (input library types and reads produced). The choice 
of library preparation method will ultimately be dependent on the task at hand. Standard 
high-throughput sequencing, combined with sufficient read depth, may still be the best 
choice for genome-sequencing projects. One barcoding approach, duplex barcoding, has 
an error rate lower than any other method because the inclusion of information from both 
strands of each DNA duplex helps to eliminate the effects of both jackpot mutations and 
damaged bases (7). Although this method is highly inefficient, duplex barcoding may be 
the method of choice in cases where single mutations, such as individual damaged bases 
in a population of DNA, must be detected (i.e., projects involving the rarest of rare 
variants). However, for many rare variant problems, circle sequencing would be a better 
choice than barcoding-based methods. Circle sequencing should be especially powerful 
in applications related to cancer profiling, immuno- genetics, microbial diversity, and 
environmental sampling. 
Superficially, our method appears to resemble the SMRTbell approach of Pacific 
Biosciences (29). This single-molecule technology also circularizes DNA and uses 
redundant information produced as a polymerase repeatedly traverses a circular template 
to reduce error. A key conceptual difference is that our method produces intermediate 
physical products containing multiple copies of the information in the templates. These 
products can then be sequenced on platforms that offer dramatically higher throughput 
and per-base-call accuracy than the single-molecule platform of Pacific Biosciences. We 
have successfully implemented our method using 2 x 150 base and 2 x 250 base reads on 
the Illumina MiSeq machine; in principle, appropriately sized circles could be used with 
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2 x 100 base reads currently available on the higher-throughput HiSeq machine. One 
technical point to consider in the application of our method is that circle sequencing 
products, because of the repetitive nature of the information contained, might be 
especially prone to problems in the clonal amplification that takes place on some high-
throughput sequencing machines. Although we did detect this phenomenon, we estimate 
that the effect is small.  
 
CONCLUSIONS 
We show that the circle sequencing method described in this chapter has an rate 
of 7.6 x 10−6 per base sequenced, dramatically improving the error rate of Illumina 
sequencing and putting error on par with low-throughput, but highly accurate, Sanger 
sequencing. In addition, circle sequencing also had substantially higher efficiency and 
lower cost than existing barcode-based schemes for correcting sequencing errors. 
Currently, we are in the process of improving this method by constructing circularized 
templates that link together both strands of double-stranded input molecules. By 
incorporating the key insight of Schmitt et al.’s duplex barcoding method (7), this 
modification could protect against errors caused by damaged bases in starting templates 
while retaining the efficiency advantages of circle sequencing. 
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Chapter 3: Rapid evolution of BRCA1 and BRCA2 in primates 
 
INTRODUCTION 
Defects in the BRCA1 or BRCA2 genes are responsible for most hereditary forms 
of breast cancer and account for as many as 10% of all breast cancer cases (30). Women 
with a strong family history of cancer who possess a harmful BRCA1 or BRCA2 allele are 
at high risk for developing breast cancer within their lifetime (80% and 60%, 
respectively) (31, 32). In addition, BRCA1 mutation carriers have a 30-40% chance of 
developing ovarian cancer, while BRCA2 mutations also increase the risk of ovarian, 
pancreatic, prostate, and male breast cancer (31). Cancers occur when heterozygous 
individuals experience a somatic loss of heterozygosity event at the BRCA1 or BRCA2 
locus, leaving only the abnormal allele intact. Because both gene products play a critical 
role in key cellular processes such as DNA repair, cell cycle control, and transcriptional 
regulation, it is clear why inactivating mutations are so detrimental. The importance of 
these proteins is further evidenced by the fact that both BRCA1 and BRCA2 null mice are 
embryonic lethal (33). 
Given their indispensible functions in maintaining the integrity of the genome, 
one might expect strict evolutionary conservation of BRCA1 and BRCA2 over time. 
Indeed, some regions of BRCA1 have experienced purifying selection strong enough to 
operate even on synonymous mutations (34). However, contrary to this line of reasoning, 
a number of groups have documented the rapid evolution of BRCA1 (12-17) and BRCA2 
(12) in mammals. Rapid evolution occurs when a gene experiences positive natural 
selection for new, advantageous mutations that arise in a population. Because 
advantageous mutations commonly involve a change in protein sequence (non-
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synonymous mutations), recurrent rounds of positive selection in a gene lead to rapid 
evolution of the encoded protein sequence over time. For BRCA1, the evolutionary rate 
was particularly elevated on the branches leading to humans and chimpanzees (Pan 
troglodytes) (13). The identification of this signature in BRCA1 suggests that some alleles 
and polymorphisms currently circulating within the human population may offer a 
selectable advantage. However, both the cause and consequence of this unexpected mode 
of evolution seen in BRCA1 remain unknown. 
Here, we report an extensive evolutionary analysis of the primate BRCA1 gene. In 
previous studies of BRCA1 evolution, only exon 11 was examined with a limited number 
of primate species included in the analyses (12-17). To extend previous studies, we have 
generated full-length BRCA1 sequences for 17 additional primate species. Using this 
more extensive dataset, we validate the finding of positive selection in humans and their 
closest ape relatives (in our study, chimpanzees and also bonobos (Pan paniscus)). We 
also show that specific codons in BRCA1 have experienced recurrent positive selection 
over evolutionary time, both within and outside of exon 11, resulting in a small number 
of highly variable residue positions in an otherwise highly conserved protein. In addition, 
we sequenced exon 11 of BRCA1 from populations of chimpanzee, bonobo, and rhesus 
macaque (Macaca mulatta) individuals and found that several unique polymorphisms 
exist within these populations. Two polymorphisms in the chimpanzee population were 
found to be in Hardy-Weinberg disequilibrium suggesting that selection may still be 
operating on this gene in modern times. Lastly, exon 11 of BRCA2, another important 
genetic determinant for hereditary breast and ovarian cancers, was also sequenced from 
diverse primate species. This gene also bears the surprising signature of positive 
selection. It is unclear why these critical genes bear this unusual evolutionary signature, 
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but we present one possible hypothesis involving interactions between DNA repair 
proteins and viruses. 
 
MATERIALS AND METHODS 
Non-human primate samples 
Of the 44 chimpanzee samples evaluated in this study, 34 were obtained from the 
Chimpanzee Biomedical Research Resource (NIH8U42OD011197-13), which is 
supported through a cooperative agreement with the National Institutes of Health (NIH). 
This NIH-supported colony is housed at the MD Anderson Cancer Center’s Michale E. 
Keeling Center for Comparative Medicine and Research (KCCMR) in Bastrop, TX. The 
origins of the chimpanzees comprising the KCCMR colony are highly diverse with only a 
few closely related (siblings/offspring) animals in the colony. Blood from 34 
chimpanzees was collected directly into PAXgene Blood RNA Tubes (PreAnalytix) at 
the same time other blood samples were obtained as part of the prescheduled annual 
veterinary exam for each animal. Another 10 chimpanzee genomic DNA samples were 
purchased from Coriell. 
All 44 rhesus macaque samples evaluated in this study were obtained from 
animals housed at the KCCMR in collaboration with researchers at this institution. The 
colony at the KCCMR is a closed breeding colony comprised of approximately 980 
rhesus macaques of Indian-origin that originated from a colony of 286 founder animals in 
1988. Blood from these animals was collected directly into PAXgene Blood RNA Tubes 
(PreAnalytix) at the same time other blood samples were obtained as part of the 
prescheduled annual veterinary exam for each animal. 
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Bonobo genomic DNA samples were obtained from the integrated primate 
biomaterials and information resource (IPBIR) of the Coriell Institute or extracted from 
blood samples obtained from the Columbus zoo and the Language Research Center, 
Georgia State University. All seven individuals are unrelated. 
The remaining non-human primate samples were acquired as cell lines purchased 
from the Coriell Institute under a U.S. Fish and Wildlife Service permit. This study was 
approved by the University of Texas at Austin Institutional Review Board. 
 
Primate BRCA1 and BRCA2 sequencing 
Human BRCA1 and BRCA2 coding sequences were obtained from GenBank 
(accession number NM 007294 and NM 000059, respectively). BRCA1 and BRCA2 
sequences from chimpanzee, gorilla, orangutan, rhesus macaque, and marmoset were 
obtained using the BLAT alignment tool on the UCSC genome database 
(http://genome.ucsc.edu/). For the remaining 18 primate sequences, primary or 
immortalized cell lines were grown in standard media supplemented with 15% fetal 
bovine serum at 37°C and 5% CO2. Cells were collected and RNA was extracted using 
the AllPrep DNA/RNA kit (QIAGEN). cDNA libraries were generated using SuperScript 
III First-Strand Synthesis Kit (Invitrogen) using oligo dT or random hexamer primers. 
PCR products were generated using PCR SuperMix High Fidelity (Invitrogen) and 
directly sequenced or cloned into pCR4 for sequencing. These sequences have been 
deposited in GenBank (accession numbers KM017616-KM017652). 
Blood from rhesus macaque and chimpanzee individuals was collected in 
PAXgene Blood RNA Tubes (PreAnalytiX). RNA was extracted using the PAXgene 
Blood miRNA Kit (QIAGEN) and genomic DNA was obtained using the AllPrep 
 34 
DNA/RNA kit (QIAGEN). BRCA1 Exon 11 was amplified from extracted genomic 
DNA (chimpanzee, bonobo, and rhesus macaque) using PCR SuperMix High Fidelity 
(Invitrogen) and sequenced.  
 
PAML analysis 
A multiple sequence alignment was generated for BRCA1 and BRCA2 using 
ClustalX2.1 (35). The alignments are straight-forward with only a few small indels. Gene 
sequences at each ancestral node were reconstructed using the codeml program in PAML 
4.3 (36). dN/dS values along each branch of the phylogenetic tree were calculated using 
the free-ratio model. Substitution counts given along specified branches are the estimates 
made in the free ratio model, but were also calculated by directly comparing the predicted 
ancestral and the known extant sequences and counting differences manually. Both 
methods yielded the same values. The one-ratio and two-ratio models were performed as 
described previously (37). To detect selection, multiple alignments were fit to the NSsites 
models M1a (null model, codon values of dN/dS are fit into two site classes, one with 
value between 0 and 1, and one fixed at dN/dS = 1), M2a (positive selection model, 
similar to M1a but with an extra codon class of dN/dS > 1), M7 (null model, codon 
values of dN/dS fit to a beta distribution bounded between 0 and 1), M8a (null model, 
similar to M7 except with an extra fixed codon class at dN/dS = 1), and M8 (positive 
selection model, similar to M7 but with an extra class of dN/dS > 1). Model fitting was 
performed with multiple seed values for dN/dS (ω) and assuming either the f61 or f3x4 
model of codon frequencies (38). Likelihood ratio tests were performed to assess whether 
permitting some codons to evolve under positive selection gives a significantly better fit 
to the data than models where positive selection is not allowed (39, 40). These different 
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model comparisons represent different trade-offs between power and accuracy (41). In all 
cases the positive selection model was a significantly better fit (p < 0.05), and individual 
codons assigned to the dN/dS > 1 class with high posterior probabilities (P > 0.85 by 
Bayes Emperical Bayes (42)) were analyzed. The crystal structure was obtained from the 
RCSB Protein Data Bank (http://www.pdb.org) and residues under positive selection 
were mapped using MacPyMol (http://www.pymol.org). 
 
Hardy-Weinberg equilibrium test 
Single nucleotide polymorphisms (SNPs) were annotated for each bonobo, 
chimpanzee, and rhesus macaque individual. Allele frequencies were calculated for each 
SNP and tested for departure from Hardy-Weinberg equilibrium (http://www.oege.org) 
(43). Chi squared values were calculated using 1 degree of freedom. A p-value (after 
Bonferroni correction) < 0.0056, 0.0056, and 0.0042 for bonobos, chimpanzees, and 
rhesus macaque, respectively, was considered statistically significant. 
 
RESULTS 
BRCA1 is evolving under positive selection in primates 
To expand our understanding of the positive selection shaping BRCA1 in 
primates, we obtained cell lines from 17 simian primate species, harvested total RNA, 
and created cDNA libraries. From these, the 5.6 kilobase full-length coding region of 
BRCA1 was sequenced. These sequences were combined with full-length BRCA1 
sequences from six primate species with available genome projects, creating an alignment 
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of 23 full-length BRCA1 sequences. 17 out of the 23 full-length sequences have never 
before been analyzed (asterisks in Figure 3-1). 
The type of selection that a gene has experienced can be inferred from its rate of 
accumulation of non-synonymous (changing the encoded amino acid; denoted dN) and 
synonymous (silent; dS) substitutions over time. Protein-altering mutations are far less 
likely to be tolerated than synonymous mutations, and so dN/dS < < 1 for the vast 
majority of genes encoded by human and other mammalian genomes (44). Some genes, 
such as pseudogenes, evolve neutrally with dN/dS ~ 1 because there is not strong 
selection for or against new mutations in these genes. Finally, selection in favor of non-
synonymous mutations results in a dN/dS > 1. These genes are classified as being under 
positive selection, and are experiencing continued selection for “innovation” at the 
protein sequence level. In these genes, not only has the penalty against protein-altering 
mutations been relaxed, but this very type of mutation is being selectively retained. Using 
PAML (45), we fit the full-length BRCA1 alignment to models of positive selection 
where a subset of codons is allowed to evolve with dN/dS > 1 (M2a, M8) and to null 
models not allowing positive selection (M1a, M7, M8a). Likelihood ratio tests revealed 
that the dataset fit the positive selection models significantly better than the null models 
(p < 0.05, Table 3-1). Thus, BRCA1 has experienced selection in favor of non-
synonymous mutations over the speciation of simian primates. 
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Figure 3-1: Evolution of BRCA1 over the course of primate speciation. dN/dS values 
for each branch of the primate phylogeny were calculated using the free-ratio model in 
PAML (45). Branches exhibiting dN/dS values > 1 are shown in bold italics. Dashes (-) 
represent branches where zero synonymous substitutions are predicted to have occurred. 
On these branches, dS = 0 and dN/dS can therefore not be calculated. In these instances, 
the numbers of non-synonymous (N) and synonymous (S) substitutions predicted to have 
occurred along each branch are indicated in parentheses (N:S). Of these, branches that 
experienced 4 or more non-synonymous changes are in bold italics. Asterisks indicate 
new sequences generated in this study.  
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M1a-M2a ω0a codon 
freq.b 
2ΔlnLc dfc p-
valuec 
M1a-M2a ω0a codon 
freq.b 
2ΔlnLc dfc p-
valuec 
BRCA1 0.4 f61 10.0 2 0.0066 BRCA2 0.4 f61 21.3 2 <0.0001 
0.4 f3x4 6.1 2 0.0466 0.4 f3x4 16.1 2 0.0003 
1.6 f61 10.0 2 0.0066 1.6 f61 21.3 2 <0.0001 
1.6 f3x4 6.1 2 0.0466 1.6 f3x4 16.1 2 0.0003 
M7-M8 ω0a codon 
freq.b 
2ΔlnLc dfc p-
valuec 
M7-M8 ω0a codon 
freq.b 
2ΔlnLc dfc p-
valuec 
BRCA1 0.4 f61 10.6 2 0.0049 BRCA2 0.4 f61 23.3 2 <0.0001 
0.4 f3x4 6.2 2 0.0447 0.4 f3x4 18.6 2 <0.0001 
1.6 f61 10.6 2 0.0049 1.6 f61 23.3 2 <0.0001 
1.6 f3x4 6.2 2 0.0447 1.6 f3x4 18.6 2 <0.0001 
M8a-M8 ω0a codon 
freq.b 
2ΔlnLc dfc p-
valuec 
M8a-M8 ω0a codon 
freq.b 
2ΔlnLc dfc p-
valuec 
BRCA1 0.4 f61 10.1 1 0.0015 BRCA2 0.4 f61 19.9 1 <0.0001 
0.4 f3x4 6.2 1 0.013 0.4 f3x4 15.1 1 0.0001 
1.6 f61 10.1 1 0.0015 1.6 f61 19.9 1 <0.0001 
1.6 f3x4 6.2 1 0.013 1.6 f3x4 15.1 1 0.0001 
a Initial seed value for ω (dN/dS). 
b Model of codon frequency. 
c Twice the difference in the natural logs of the likelihoods (2 × ΔlnL) of the two models being compared (a model that  
allows positive selection (M2a or M8) is compared to a null model (M1a, M7, M8a)). This value is used in a likelihood 
ratio test along with the degrees of freedom (df). The p-value indicates the confidence with which the null model can be 
rejected. 
Table 3-1: PAML analysis of BRCA1 and BRCA2. 
We next estimated dN/dS values on each branch on the primate evolutionary tree 
using the free-ratio model in PAML. As expected, most branches exhibited a dN/dS < 1 
(Figure 3-1). The branch leading to humans had the most elevated signal with a dN/dS of 
2.79. The second highest value of dN/dS on the BRCA1 tree is found on the branch 
leading to the last common ancestor of bonobos and chimpanzees, with a dN/dS of 2.66. 
Because the free-ratio model is highly parameterized, we next compared one-ratio and 
two-ratio models to determine whether selection has differentially affected the human, 
chimpanzee, and bonobo clade. As shown in Figure 3-2, our simian primate dataset fit the 
two-ratio model significantly better than the one-ratio model, with the human, 
chimpanzee, and bonobo clade exhibiting a dN/dS of 1.78, while all other branches had a 
dN/dS of 0.59. In summary, our extended primate dataset shows that BRCA1 is 
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experiencing positive selection, and that the most intense selection has operated on the 
human/chimpanzee/bonobo clade.  
 
 
Figure 3-2: BRCA1 has been evolving differentially during primate speciation. The 
human, bonobo, and chimpanzee clade was isolated and dN/dS values were calculated 
using the one-ratio and two-ratio models in PAML. The two-ratio model was a better fit 
as determined by the likelihood ratio test shown in the box. ω0 is the calculated dN/dS 
for all branches under the one-ratio model, or for background branches under the two-
ratio model, and ω1 is the dN/dS for the isolated branches in the two-ratio model. 
Based on a comparison of extant and predicted ancestral sequences, humans are 
estimated to have accumulated 25 substitutions in the BRCA1 gene since their divergence 
from chimpanzees and bonobos six million years ago, 22 of which are non-synonymous 
(Figure 3-3A). In order to understand how unusual this is, we looked at the evolution of 
other genes, specifically ones encoding BRCA1-interacting proteins, along the branch 
leading to humans. Because we do not have extended sequence sets for all of these genes, 
we took a simpler approach. For each gene, we aligned the human, chimpanzee, and 
gorilla sequences and manually counted the number of human-specific substitutions (any 
position where the human gene sequence differs from both the chimpanzee and gorilla 
gene sequence). These were categorized as non-synonymous (N) or synonymous (S) 
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based on how they affected the codon in which they were found. When these values are 
normalized to gene size, BRCA1 has the highest enrichment of non-synonymous 
substitutions [(N/kb) / (S/kb)]. Care must be taken in comparing this metric between 
genes, because different genes have different equilibrium codon frequencies, and 
therefore have different mutational opportunities for synonymous and non-synonymous 
mutations. However, the BRCA1 gene has an enrichment ratio that is more than 4-fold 
higher than any of the other genes shown (Figure 3-3B). 
 
 
Figure 3-3: BRCA1 evolution in the human, bonobo, and chimpanzee clade. (A) 
dN/dS values for BRCA1 were calculated on each branch of the using the free-ratio model 
in PAML. dN/dS values > 1 are shown in bold italics. The numbers of non-synonymous 
(N) and synonymous (S) substitutions predicted to have occurred along each branch are 
indicated in parentheses (N:S). The asterisk represents the last common ancestor of 
humans, bonobos, and chimpanzees. MYA, million years ago. (B) The number of human-
specific non-synonymous (N) and synonymous (S) substitutions in BRCA1 and other 
genes encoding BRCA1-interacting proteins. The length of each gene is shown in 
kilobases (kb). Non-synonymous and synonymous substitutions are shown as number of 
substitutions per kilobases (N/kb and S/kb, respectively). An “enrichment ratio” of N/kb 
over S/kb was also calculated.  
BRCA1 encodes a 220 kDa protein with two conserved domains: an N-terminal 
RING domain and two tandem C-terminal BRCT domains (Figure 3-4). The RING 
domain has E3 ubiquitin ligase activity that is essential in the DNA damage response. 
The BRCT motifs function as a protein-protein interaction module that binds 
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phosphorylated proteins involved in DNA repair, cell cycle control, chromatin 
remodeling, and transcription. There is also a coiled-coil region between these two 
domains. Interestingly, all but one of the non-synonymous substitutions predicted to have 
occurred in the human/bonobo/chimpanzee clade fall outside of these known structural 
motifs (Figure 3-4). 
 
 
Figure 3-4: Substitutions in the BRCA1 gene of human, bonobo, and chimpanzee. A 
domain diagram of BRCA1 is shown with the RING domain, coiled-coil domain (C-C), 
and BRCT domains indicated. On this are superimposed all of the non-synonymous 
substitutions predicted to have occurred in the tree shown in panel A since the divergence 
of humans, bonobos, and chimpanzees from their last common ancestor (asterisk in A). 
Vertical lines indicate substitutions specific to humans, lines with white circles are 
substitutions specific to bonobos, and lines with grey circles are substitutions specific to 
chimpanzees. Lines with black circles indicate substitutions common to both bonobos 
and chimpanzees. 
 
Human variation at selected sites in BRCA1 
The M8 model allows a class of codons to evolve under positive selection (dN/dS 
> 1). 10 codons were identified as belonging to this class with a high posterior probability 
(P = 0.85 or above). These codons do not lie in the region of BRCA1 where it was 
previously reported that selection might be acting against synonymous mutations (34), 
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potentially given rise to a false signature of dN/dS > 1. Instead, all 10 sites show high 
variability between primate species at the protein level, often encoding very dissimilar 
amino acids (first four rows in Figure 3-5). Next, these positively selected codon 
positions were examined for variability within the human population. The Breast Cancer 
Information Core (BIC, http://research.nhgri.nih.gov/bic/) is a repository of human 
BRCA1 polymorphisms. Using this database, we identified single nucleotide 
polymorphisms (SNPs) at amino acid sites 170, 888, 890, 1203, and 1443 (Figure 3-5). 
At four out of these five sites (position 888, 890, 1203, and 1443), we find that some 
human BRCA1 alleles encode a unique amino acid not observed in any of our primate 
sequences. In addition, SNPs known to cause human disease occur in six out of 10 sites. 
In all cases, these disease-linked SNPs are not amino acid-altering mutations, but rather 
more radical frame-shifting or nonsense mutations (Figure 3-5). In particular, nonsense 
mutations occurring in codon 1443 are among the most common mutations documented 
in the BIC.  
 
 
Figure 3-5: Specific codons in BRCA1 have experienced positive selection during 
primate speciation. Shown are the ten codons that have evolved under positive selection 
(dN/dS > 1) in primates with a P>0.85. Codons with a P>0.95 are indicated with 
asterisks. The amino acids encoded at these positions in human BRCA1 are shown, along 
with those found in hominoids, old world monkeys, and new world monkeys. In addition, 
human SNPs and disease mutations also found at these sites are listed. X refers to a single 
nucleotide mutation that results in a termination codon.  
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In Figure 3-6, all 10 sites of positive selection were mapped onto a domain 
diagram of BRCA1 (bottom) along with the most common human non-synonymous 
SNPs found in the BIC (top). As described previously for mutations accumulated in the 
human/chimpanzee/bonobo clade, all but one of the positively selected residues (1370S 
in the coiled-coil domain) lie outside of any known structural motifs. In summary, the 10 
codon positions identified in this analysis are highly variable between primate species 
and within the human population, and are involved in the etiology of cancers associated 
with this gene. Disease-associated SNPs at these sites tend to be radical, protein-
truncating mutations. However, a presumably distinct phenomenon appears to be driving 
selection in favor of non-synonymous point mutations at these positions. 
 
 
Figure 3-6: Sites of positive selection on the BRCA1 protein. A domain diagram of 
BRCA1 is shown with the RING domain, coiled-coil domain (CC), and BRCT domains. 
The triangles at the bottom represent sites of positive selection (grey - P>0.85, black - 
P>0.95). The 12 most common human variants recorded in the BIC are shown at the top 
of the diagram as stars. The black stars indicate disease-causing mutations, white stars 
represent variants with no known clinical significance, and grey stars are those with 
unknown significance.  
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BRCA1 variation in other primate populations 
So far, we have documented sequence differences between the BRCA1 proteins 
of different primate species. We have shown that non-synonymous substitutions are 
accumulating in BRCA1 faster than expected under constrained, or even neutral, 
evolution. We next wished to explore whether positive selection is still acting on BRCA1 
in modern populations. There is already evidence that this is true in the human 
population, because several BRCA1 SNPs have been found to depart from Hardy-
Weinberg equilibrium in European populations (46, 47) and in Australia (13). We wished 
to determine if the same might be true in bonobo and chimpanzee populations. We 
amplified and sequenced the largest BRCA1 exon, exon 11 which is ~3.4 kilobases and 
comprises ~61% of the BRCA1 coding region, from the genomic DNA of seven bonobo 
and 44 chimpanzee individuals (Table 3-2). In bonobos, we found nine polymorphic 
sites, eight of which were single nucleotide polymorphisms (SNPs), with three of these 
being non-synonymous. Eight of the SNPs were in Hardy Weinberg equilibrium. 
Interestingly, one bonobo individual was also homozygous for a seven amino acid 
deletion (Δ1058-1064) (Table 3-2). Hardy-Weinberg equilibrium was rejected for this 
polymorphism, although the support was weak and did not survive correction for multiple 
testing (Table 3-2). The chimpanzee sequence set revealed nine SNPs, seven of which 
were non-synonymous. Interestingly, in this larger sample set (n = 44), three of the non-
synonymous SNPs were found to be in Hardy Weinberg disequilibrium, suggesting that 
selection is acting either for (E309K and G590S) or against (G1077R) these mutations. 
The support for one of these (E309K) was weak and did not survive correction for 
multiple testing (Table 3-2). It is particularly intriguing to see that humans also share 
with chimpanzees this same S/G SNP at position 590. In both the bonobo and 
chimpanzee populations, all synonymous SNPs were in Hardy-Weinberg equilibrium. 
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Species SNPsa Genotype p- 
valueb 
Humanc Human Polymorphisms 
AA AB BB BICd 1000 genomese 
Bonobo  
n = 7 
I493L 6 1 0 0.841 I   
T582M 6 1 0 0.841 T   
L833L 4 3 0 0.471 L dupAAGTATCCAT*  
V1047V 5 1 1 0.128 V   
G1048G 5 1 1 0.128 G G1048D, G1048V, G1048G G1048D, G1048V, G1048G 
T1051I 5 1 1 0.128 T   
Δ1058-1064HWD 6 0 1 0.008    
V1061V 6 1 0 0.841 I delA* delA* 
G1062G 6 1 0 0.841 G   
Chimpanzee  
n = 44 
E309KHWD 19 14 11 0.023 K K309T K309Q, K309T 
E427K 34 9 1 0.663 E   
S578S 40 4 0 0.752 S S578Y S578Y 
G590SHWD 20 12 12 0.004 S S590G S590G 
K731E 19 16 9 0.122 K delAGAAG* delAGAAG* 
I925T 34 9 1 0.663 I I925L I925V, I925L, insT* 
S1042S 41 3 0 0.823 S   
G1077RHWD 42 1 1 1.4E-5 G  G1077W, G1077G 
G1100E 20 16 8 0.155 G   
Rhesus  
n = 44 
A225A 42 2 0 0.888 A   
N375S 43 1 0 0.920 N delA*, N376S delA*, N376S 
R466R 42 2 0 0.888 K K467X* K467X* 
T487S 43 1 0 0.920 T insA* insA* 
N684N 29 14 1 0.647 N   
V739M 38 6 0 0.624 V V740L V740L, insA* 
D773G 29 15 0 0.173 G   
D852D 40 4 0 0.752 D insA* insA* 
N923H 40 4 0 0.752 N   
K936K 40 4 0 0.752 K   
A1167E 40 4 0 0.752 A   
Q1203R 29 14 1 0.647 R R1203Q, R1203G, R1203X* R1203Q, R1203G, R1203X* 
a Numbering refers to the amino acid position in the respective primates. In the case of rhesus macaques, amino acids 
375 to 936 correspond to amino acids 376 to 937 in humans. 
b p-values were calculated using a chi-squared test with a df = 1. A p-value cutoff (after Bonferroni correction) < 
0.0056, 0.0056, and 0.0042 for bonobos, chimpanzees, and rhesus macaque, respectively, was considered statistically 
significant. Tests that survived this correction have the p-value listed in italics. 
c Amino acid found in the human BRCA1 protein at each of the positions listed. 
d Human variants found at the positions indicated in the Breast Cancer Information Core. 
e Human variants found at the positions indicated in the 1000 Genomes database. 
* Known human disease-causing variant. 
HWD SNPs found to be in Hardy-Weinberg Disequilibrium. 
Table 3-2: SNP Analysis of BRCA1 in Bonobo, Chimpanzee, and Rhesus Macaque 
Individuals 
We also sequenced exon 11 from 44 rhesus macaque individuals. Rhesus 
macaques are not part of the human/chimpanzee/bonobo clade and are instead distantly-
related members of the Old World monkey clade (Figure 3-1). In these macaques, we 
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found 12 SNPs in BRCA1, with seven being non-synonymous (Table 3-2). This includes 
a SNP found at position 1203, a site of positive selection in the inter-species dataset. This 
codon is also the site of a known disease-linked mutation in humans; however, the 
cancer-linked SNP at this position introduces a stop codon. Nonetheless, all of these are 
in Hardy-Weinberg equilibrium. 
Caution must be used when interpreting signatures of selection acting on 
polymorphisms in primate populations. When sampling primates, it is not possible to get 
completely random and non-related population sets. Deviations from Hardy-Weinberg 
equilibrium may occur due to factors other than selection. Reasons for falsely rejecting 
Hardy Weinberg equilibrium include 1) non-random mating, 2) small population sizes 
which magnify the effects of genetic drift, 3) introduction of new alleles, 4) population 
subdivision or admixture, 5) biases in sequencing errors, and 6) linkage disequilibrium 
with another locus under selection. Because the chimpanzee population consists of 
individuals from two different subspecies, admixture could plausibly lead to rejection of 
Hardy Weinberg equilibrium. 
We also performed the McDonald-Kreitman and Tajima’s D tests on our datasets 
(data not shown). The tests were not significant and therefore do not support selection 
acting on any of these polymorphisms. False conclusions in this test can again result from 
a population with hidden structure. In summary, while the analyses using the simian 
primate dataset consisting of 23 species suggest that recurrent positive selection has been 
acting on BRCA1 over the course of several million years, the Hardy-Weinberg 
equilibrium tests performed here and by others indicate that selection is acting on modern 
day humans, and possibly also chimpanzees. 
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BRCA2 is also evolving under positive selection in primates 
Because of the rapidly evolving nature of BRCA1, we also completed an 
evolutionary analysis of BRCA2, another strong determinant for hereditary breast and 
ovarian cancer. Although BRCA2 has been shown to be under positive selection, only a 
small number of primate species was included in this study (12). We sequenced the ~5 
kilobase exon 11 from 18 primate species. Exon 11 is the largest of 27 exons and encodes 
about 50% of the entire BRCA2 protein. The sequences, along with six additional 
sequences from available genome projects, were assembled into a multiple alignment. 
We fit the alignment to positive selection and null models as described above. The 
positive selection models were again a significantly better fit to the sequence set than the 
null models, with a p value ≤ 0.0003 (Table 3-1). In summary, BRCA2 is under positive 
selection in primates as well, although this signature appears not to be concentrated on 
the human/chimpanzee/bonobo clade. 
In contrast to BRCA1, BRCA2 is a 390 kDa nuclear protein that is exclusively 
involved in the homologous recombination pathway for repairing double-strand breaks. 
The eight BRC motifs and the extreme C terminus mediate interactions with and 
recruitment of Rad51, a protein that catalyzes strand invasion during homologous 
recombination (48-50). All eight BRC repeats are encoded within exon 11. The M8 
model estimates that five codons are evolving under positive selection with posterior 
probability > 0.85 (Figure 3-7A). Two of these positively selected sites were found to 
have a human polymorphism documented in the BIC (Figure 3-7A). When all five sites 
of positive selection are mapped onto a domain diagram of BRCA2 (Figure 3-7B), they 
cluster within the first three BRC domains (1008, 1225, and 1426) and the intervening 
regions (1159 and 1272).  
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Figure 3-7: Codons in exon 11 of BRCA2 that have experienced positive selection in 
primates. (A) 5 codons in exon 11 of BRCA2 were found to be under positive selection 
in primates. All sites had a P>0.95 (indicated with asterisks) except for S1008 (P=0.9). 
The amino acid encoded by human BRCA2 at each of these codons is shown. The amino 
acids encoded by hominoids, old world monkeys, and new world monkeys are also 
shown. Human SNPs and disease mutations deposited to the BIC are listed at the bottom. 
(B) A domain diagram of BRCA2 is depicted with the 8 BRC repeats, helical DNA 
binding domain (helical DBD), OB folds, and nuclear localization signals (NLS). Only 
exon 11 was sequenced in this study (section in white). The sites of positive selection are 
represented as triangles at the bottom of the diagram. The 11 most common protein-
altering variants in the BIC are marked as stars at their respective locations at the top. 
Black stars correspond to disease-causing mutations, white stars are variants with no 
known clinical significance, and grey stars are positions with unknown significance.  
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Figure 3-8: The sites of positive selection lying within the BRC repeats of BRCA2 
are located adjacent to the Rad51 binding region. (A) The 8 BRC repeats of the 
human BRCA2 protein were aligned using ClustalX. The red and peach colored boxes 
are the motifs within the BRC repeats thought to facilitate binding with Rad51 (51). 
Residues 1008, 1225, and 1426 are colored in green, orange, and yellow, respectively. 
All three sites lie just adjacent to the FxxA motif which interacts with two hydrophobic 
pockets in the Rad51 oligomer. (B) The co-crystal structure of BRC4 (blue) in complex 
with Rad51 (grey) is shown (PDB ID 1N0W (52)). The FxxA motif is depicted in red.  
Residues 1008, 1225, and 1426 are shown in green, orange, and yellow, respectively.   
To examine this further, we aligned the amino acid sequence of all eight BRC 
repeats of human BRCA2 and highlighted sites 1008, 1225, and 1426 (Figure 3-8A). 
Surprisingly, all three sites of positive selection lie adjacent to a hydrophobic motif 
(FxxA) known to mediate interactions with Rad51 (Figure 3-8A red box). Since the co-
crystal structure of the BRCA2 BRC4 in complex with Rad51 is available, we mapped 
these three sites to their analogous positions in BRC4 and found that they are in close 
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proximity to the Rad51 binding interface (Figure 3-8B, PDB: 1N0W) (52). The clustering 
of these residues near this interface might provide a clue to the driver of natural selection 
at these sites. 
 
DISCUSSION 
Nearly all known cases of recurrent positive selection in primate genomes involve 
genes in one of three categories: 1) immunity, 2) environmental perception (such as 
odorant and taste receptors), or 3) sexual selection and mate-choice (53, 54). This is due 
to the fact that ever-changing external stimuli (i.e. pathogens, environmental odors/tastes, 
etc.) drive the selection of new allelic variants. For example, immunity factors that are 
constantly challenged by pathogens exhibit some of the most striking signatures of 
positive selection seen in primate genomes (55-60). Here, immunity genes will 
experience positive selection for protein-altering mutations that improve recognition of a 
relevant pathogen. Conversely, the pathogen will counter-evolve to escape detection, 
again placing selective pressure on the host population for new mutations that improve 
the immunity protein. This cycle can repeat itself indefinitely, resulting in an ever-
escalating host-virus arms race. Therefore, it is surprising to see that BRCA1 and BRCA2, 
genes that do not classically fit into any of the three categories listed above, are evolving 
in a similar manner to these highly adaptive immunity genes. In addition to the two 
described here, other DNA repair genes have also been shown to evolve under positive 
selection (11, 61), but the driver behind this unusual finding remains to be identified. 
An intense battle exists between host DNA repair machinery and viruses, and we 
propose that this could contribute to the evolutionary signatures documented here. Many 
viruses are known to interact with the DNA repair machinery and cell cycle regulators 
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(62, 63). One fundamental issue is that the free ends of viral genomes are exposed, in 
contrast to the host’s DNA, which is capped by telomeres. Despite this, many viruses 
need to access the nucleus where the host’s DNA repair machinery recognizes these un-
capped viral genome ends as “damaged” cellular DNA, activating the DNA damage 
response. In order for productive infection to proceed, viruses must actively thwart these 
host repair pathways. For example, DNA repair proteins interfere with the adenovirus 
lifecycle by concatenating the ends of newly synthesized viral DNA, inhibiting efficient 
packaging into viral progeny (64). In turn, adenovirus has evolved a way around this 
blockade by encoding proteins that mislocalize or degrade the specific host factors 
involved. Depending on the virus involved, host DNA repair factors can also be hijacked 
to facilitate viral replication. For instance, herpes simplex virus-1 simultaneously 
activates DNA repair constituents that aid in viral genome replication (65, 66) and 
counteracts those that do not (67, 68). Human immunodeficiency virus 1 is also known to 
activate the DNA damage response and manipulate cell cycle checkpoints through the 
actions of its accessory protein Vpr (69, 70). Additionally, several studies have shown 
that specific DNA repair proteins play critical roles in retroviral genome integration (71-
74) while others seem to decrease the efficiency of infection (75-77). 
One can imagine that these and other viruses that access the nucleus during 
replication could feasibly interact with BRCA1 or BRCA2, driving the selection of 
variants that ultimately lead to decreased susceptibility to infection. However, it is 
possible that variant alleles selected for this purpose would have detrimental 
consequences to protein function in the context of host DNA repair. Most of the 
deleterious BRCA1 and BRCA2 variants characterized thus far introduce stop codons or 
frame-shifts that result in premature truncation of the protein, the consequences of which 
manifest as cancer at relatively early ages. The effects of non-synonymous point 
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mutations, such as those documented here, might be expected to be much more subtle. 
The effects of subtle mutations are more difficult to assess because the resulting genomic 
instability may only be realized later in life and can be confounded by other genetic or 
environmental influences. We therefore propose a hypothesis where viruses are driving 
the intriguingly rapid rate of evolution seen in BRCA1 and BRCA2, potentially giving rise 
to antagonistic pleiotropy. This would be analogous to the malaria and sickle cell anemia 
trade-off that is well documented (78). 
 
CONCLUSIONS 
The BRCA1 and BRCA2 proteins play key roles in the repair of damage to 
chromosomal DNA. We have expanded the analysis of the evolution of these genes, 
showing that both have been subject to recurrent positive selection during simian primate 
speciation. Although the force or forces driving the diversifying selection of these genes 
is unknown, the result is that the sequence of these proteins has been altered in humans 
and our closest living relatives. It remains to be seen whether this is an instance of 
antagonistic pleiotropy, where positive selection driven by one force causes functional 
consequences in another context, potentially the formation of cancers (79). 
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Chapter 4: A DNA repair protein constitutes a barrier to cross-
species transmission of herpes simplex virus 1 in primates 
 
INTRODUCTION 
More than half of the human population and greater than 90% of adults over the 
age of 50 are infected with herpes simplex virus 1 (HSV-1), making it one of the most 
omnipresent viruses circulating in humans today (80). From an evolutionary perspective, 
the ability to cause mild clinical disease and establish a lifelong infection makes HSV-1 
perhaps one of the most successful viruses of all time. In addition, a plethora of viral gene 
products is devoted to disarming or hijacking host protein functions during the course of 
infection. This clearly demonstrates that HSV-1 has finely tuned its interactions with its 
host in order to establish a delicate balance between optimal replication and survival, a 
product of long-term adaptation of a virus to its host (22, 44).  
Many other non-human primate species also harbor their own simplex virus 
variants with which they have coevolved. The phylogenetic relationship between these 
simplex viruses mirrors that of their primate hosts, providing strong evidence for 
codivergence as the principal mode of primate simplex virus evolution (Figure 4-1) (81-
84). Although each simplex virus species is genetically distinct from one another, enough 
similarities exist to allow for rare cross-species transmissions to occur in nature. One 
such example is the zoonotic transmission of macaque simplex virus 1 (MHV-1), also 
known as the herpes B virus, from macaques to humans (20). Although the virus causes 
little to no disease in its cognate host species, the virus spreads to the central nervous 
system in humans and ultimately causes permanent neurological deficits or even death. In 
persons who develop encephalomyelitis, the mortality rate is estimated to be about 80% 
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without antiviral treatment, illustrating the potential zoonotic threat that primate simplex 
viruses can cause to human health (85). More recently, a study revealed that the 
acquisition of herpes simplex virus 2 in a human ancestor was most likely the result of a 
cross-species transmission event of a chimpanzee herpes simplex virus (84). Conversely, 
infection of non-human primate species with HSV-1 can manifest in severe illness, often 
times resulting in death (86-88).  
 
 
Figure 4-1: Primate simplex viruses and their natural hosts. The phylogenetic 
relationship of primate simplex viruses exactly mirrors that of the primate hosts (grey 
dotted lines), a finding that is consistent with codivergence. However, cross-species 
transmission events have been documented to occur in nature (red dotted lines), resulting 
in severe disease and often times death. All viruses shown in this figure have been 
isolated and sequenced with the exception of the gorilla herpes virus. 
Interestingly, the large discrepancy in virulence of a single virus can be attributed 
to a small number of genetic differences between the host and non-host species it is able 
to infect (22). For example, the human genome is remarkably similar to that of the rhesus 
macaque genome, exhibiting 93% sequence identity (89). This means that less than 7% of 
the genome dictates whether MHV-1 can successfully infect humans and the severity of 
clinical disease that follows. Within this 7% are host genes that play critical roles in the 
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viral lifecycle and are the key determinants of cross-species transmission events. 
Therefore, to better understand the dynamics of cross-species transmission of viruses, it is 
of considerable interest to identify these host genes and if genetic differences between 
host and non-host species have a differential impact on viral replication.  
For HSV-1, genes involved in the DNA damage response are potential candidates 
that may be crucial in modulating its pathogenicity. Amazingly, HSV-1 has evolved the 
ability to selectively activate specific arms of the DNA damage response that enhance its 
replication (65, 66, 90-92), while disabling those that are counterproductive to infection 
(67, 68, 93-97). In particular, the Mre11-Rad50-Nbs1 (MRN) complex, an early sensor of 
DNA damage, localizes to viral replication centers in actively infected cells (65, 90, 91). 
It has been shown that the presence of Mre11 drastically increases viral DNA replication 
and virus production, implicating the MRN complex as a cofactor in the HSV-1 lifecycle 
(65). In addition, several groups have reported an interaction between the MRN complex 
and HSV-1 proteins. A proteomic screen of host proteins that co-precipitated with the 
viral single-stranded DNA binding protein ICP8 revealed a potential interaction with 
Mre11 and Rad50 (98). The MRN complex has also been shown to physically interact 
with the HSV-1 exonuclease UL12 (99), while a peptide fragment of the multifunctional 
ICP0 protein was able to bind Nbs1 (97).  
Previously, we reported that Nbs1 and several other DNA repair proteins have 
been the subject of intense positive selection in primates, with each primate species 
encoding different variants (11, 100). This is extremely unusual because rapidly evolving 
genes are known to be exclusively involved in environmental perception, sexual 
selection, and immunity (53, 54). In particular, because of the intimate relationship 
between HSV-1 and the MRN complex, we hypothesized that specific amino acid 
differences between the primate Nbs1 proteins could differentially affect the HSV-1 
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lifecycle. In this study, we tested the ability of several primate orthologs of Nbs1 to 
support HSV-1 replication and examined the role that Nbs1 plays in the viral lifecycle.  
 
MATERIALS AND METHODS 
Cell lines 
NBS-ILB1 cells were grown in DMEM supplemented with 10% FBS, 100 µg/ml 
streptomycin, and 100 U/ml penicillin at 37°C and 5% CO2. Cell lines stably expressing 
primate Nbs1 proteins with a c-terminal FLAG tag were generated using a retroviral 
transduction system and maintained under selection with media containing 800 µg/ml of 
G418 for at least 1 month. Expression of Nbs1 proteins was detected by Western blot 
using the Nbs1 specific antibody, Y112 (Genetex). Vero, U2OS, HEK-293, HEK-293Ts, 
and MDCK cells were purchased from ATCC and cultured in DMEM with 10% FBS and 
Penn/Strep. 
 
Antibodies 
Primary antibodies were purchased from Genetex (Nbs1 Y112, Mre11 12D7), 
Santa Cruz (actin, Rad50), Sigma (FLAG M2), and Abcam (GFP). The anti-Udorn 
antibody was a kind gift from Dr. Robert M. Krug. All secondary antibodies were 
purchased from Thermo Scientific. 
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Viruses 
HSV-1 
The HSV-1 strain 17 in1863 variant containing the lacZ gene in the thymidine 
kinase region was a kind gift from Dr. Chris Preston. The dl1043 virus has a 2 kb 
deletion in both copies of ICP0 and was obtained from Dr. Matthew Weitzman (101). 
The FXE virus encodes for ICP0 with a deletion in the RING domain (amino acids 106-
149) and was also obtained from Dr. Matthew Weitzman (102). All virus stocks were 
grown on Vero cells. The in1863 strain was titered on either Veros or U2OS cells while 
the ICP0 mutant viruses (dl1043 and FXE) were titered on U2OS cells. Infections were 
conducted on cell monolayers at the indicated MOIs in serum free media for 1 hour at 
37°C. The cells were washed with PBS and complete media containing 10% FBS and 
Pen/Strep was added. Unless otherwise noted, supernatant from infected cells were 
collected at the indicated timepoints.  
For plaque assays, 10-fold serial dilutions were made and titered on the relevant 
cell lines as described above. After 1 hour of adsorption, media containing 10% FBS and 
1% human serum was added. Plaques were stained using a 0.5% crystal violet, 25% 
methanol solution after 2-3 days. For plaque assays using the in1863 virus, cells were 
fixed with 2% paraformaldehyde and stained with an X-gal staining solution.   
Adenovirus 
Wild-type adenovirus serotype 5, recombinant adenoviral vectors encoding 
E1b55k and E4orf6, and the E4-deleted dl1004 virus were obtained from Matthew 
Weitzman. Cells were infected with adenovirus at the indicated MOI for 2 hours in 
DMEM with 2% FBS. After adsorption, the media was replaced with DMEM containing 
10% FBS and Pen/Strep. Supernatants were harvested at the indicated timepoints. 
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Titering was performed on HEK-293 cells using the Adeno-X Rapid Titer Kit (Clontech). 
Whole cell lysates were harvested after 96 hours post infection and subjected to 
immunoblotting as described below. 
Influenza 
Single-cycle and multiple cycle influenza A virus infections (A/Udorn/H3N2; a 
kind gift from Robert M. Krug) were carried out at 2 MOI. Cells were washed with PBS 
and then incubated in infection media (DMEM supplemented with Pen/Strep, L-Glut, and 
1% BSA) for one hour at 37°C. Cells were washed once more in PBS and incubated in 
influenza growth media (DMEM supplemented with Pen/Strep and L-Glut; multiple-
cycle samples also included 0.5ug/ml N-acetylated trypsin). For single-cycle infections, 
cell lysates were harvested at 8 hours post infection using RIPA buffer supplemented 
with complete protease inhibitor (Roche) and PMSF (Invitrogen). Whole cell lysates 
were subjected to western blotting and influenza proteins were visualized using a 
polyclonal anti-Udorn antibody. For multiple-cycle infections, each cell line was seeded 
in triplicate and infected with a unique dilution of influenza A virus. Supernatants were 
collected at 1, 12, 24, and 48 hours post infection and titered by carrying out a plaque 
assay on MDCK reporter cells. Infections for plaque assays were carried out as described 
above, except the final incubation media contained 1.4% Avicel (Sigma) to induce plaque 
formation.  
 
Immunoprecipitation and immunoblotting 
MRN co-IP 
NBS-ILB1 cells expressing empty vector, human, or white-cheeked gibbon Nbs1 
were lysed in ice-cold lysis buffer (50 mM Tris pH 7.5, 150 mM NaCl, 0.5% NP-40) and 
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rotated for at least 1 hour at 4°C. The lysates were cleared and a small aliquot was saved 
as the input sample. The remaining samples were incubated with 10 µl of anti-
DYKDDDDK conjugated magnetic beads (Syd labs) at 4°C for at least 2 hours. The 
beads were washed 3 times with lysis buffer and 3 times with Buffer A (25 mM Tris pH 
8, 100 mM NaCl, 10% v/v glycerol, 1 mM DTT). Bound proteins were eluted with a 
DYKDDDDK peptide. SDS loading buffer was added to the samples and boiled for 10 
minutes. The samples were separated via electrophoresis on a polyacrylamide gel and 
transferred to a nitrocellulose membrane. The membrane was blocked in 5% milk in 
TBS-T and immunoblotting was carried out using a primary antibody and the appropriate 
HRP-conjugated secondary antibody. Amersham ECL Prime Western Blotting Detection 
Reagent (GE Life Sciences) was used for visualization.  
ICP0 and Nbs1 co-IP 
HEK-293Ts were transfected with the indicated plasmids using Lipofectamine 
2000 (Invitrogen) according to the manufacturer’s protocol. At 48 hours post 
transfection, cells were harvested in 500 µl of ice-cold co-IP buffer with protease 
inhibitors (50 mM Tris-HCl pH7.4, 150 mM NaCl, 0.1% Triton X-100, 50 mM NaF, 1 
mM sodium vanadate) and subjected to mild sonication. The lysates were cleared and a 
small aliquot was saved as the input sample. The remaining samples were incubated with 
the anti-GFP antibody (Abcam) for at least 2 hours at 4°C with constant rotation. 
Dynabeads Protein G (Novex) were then added to the samples and rotated at 4°C for at 
least 1 hour. The beads were washed four times with ice-cold co-IP buffer and 
resuspended in SDS loading buffer. Immunoblotting was performed as described in the 
previous section. 
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DNA repair assays 
Cells were plated at a density of 200 cells per well in 6 well plates. The following 
day, media containing the appropriate concentrations of either camptothecin (Sigma) or 
hydroxyurea (Sigma) were added to the cells. 24 hours later, the media was replaced with 
fresh media. For X-ray irradiation experiments, the cells were subjected to the doses 
indicated using the Faxitron X-ray system at 120 kV and 5mA. All cells were grown to 
allow for colony formation at 37°C for at least 7 days. Colonies were stained with a 
crystal violet staining solution, washed, and counted. Cell counts from treated wells were 
normalized to untreated controls and expressed as percent survival. 
 
Viral DNA detection 
Cells were infected with HSV-1 or adenovirus and collected at the indicated 
timepoints. Viral DNA was extracted from cells using the DNeasy Blood and Tissue Kit 
(QIAGEN) and quantified by amplifying the ICP27 gene for HSV-1 and DBP for 
adenovirus. These values were normalized to an endogenous control gene such as RPLP0 
or tubulin and then to the 4 hour input sample. Products were amplified using the Power 
SYBR Green PCR Master Mix (Applied Biosystems) on the ViiA7 Real-Time PCR 
System (Applied Biosystems). 
 
RESULTS 
Species-specific effects of Nbs1 on HSV-1 replication 
While NBS1 has been rapidly evolving over the course of primate speciation, the 
genes encoding the remaining members of the MRN complex, RAD50 and MRE11, do 
not display the same pattern (11). In fact, the Mre11 and Rad50 proteins encoded by 
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orangutan, white-cheeked gibbon, and rhesus macaque are greater than 99% identical in 
amino acid composition to the human proteins, while the Nbs1 proteins encoded by these 
species show greater levels of divergence from the human Nbs1  (Figure 4-2A). These 
non-human primate Nbs1 proteins differ by 21 to 36 amino acids from the human 
homolog.  Furthermore, these differences are scattered throughout the length of the 
protein (Figure 4-2B). It is interesting to note that key regions of the protein known to 
mediate critical protein-protein interactions with other DNA repair factors, such as Mre11 
and ATM, are essentially conserved in all primate orthologs of Nbs1 (alignment shown in 
Figure 4-3).  
 
 
Figure 4-2: Nbs1 exhibits the greatest sequence divergence in primates. (A) The 
human Mre11, Rad50, or Nbs1 amino acid sequence was aligned to the orangutan, white-
cheeked gibbon, or rhesus macaque protein sequence and the percent protein identity was 
calculated. (B) Amino acid differences in the primate Nbs1 orthologs when compared to 
human Nbs1. Tick marks represent positions in which the primate Nbs1 ortholog encodes 
a different amino acid than the human Nbs1 protein. Red tick marks represent sites under 
positive selection as described previously (11). 
Although the role of Nbs1 has never been directly characterized in the HSV-1 
lifecycle, previous work has shown that HSV-1 titers are reduced by greater than 10 fold 
in the absence of Mre11, suggesting that either Mre11 or the MRN complex acts as a 
cofactor in the HSV-1 lifecycle (65). To test whether Nbs1 also has a positive effect on 
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the HSV-1 lifecycle, we obtained a cell line hypomorphic for Nbs1, NBS-ILB1 (103), 
and stably complemented it with the human NBS1 allele or the empty vector (ΔNBS1). 
Cells were infected with a wild-type HSV-1 strain encoding the lacZ gene at a 
multiplicity of infection (MOI) of 0.01 and virus production was measured (Figure 4-4A). 
At 24 hours post infection, viral titers in the supernatant were significantly increased in 
cells expressing human Nbs1 (red bar) when compared to the parental cell line (ΔNBS1, 
blue bar). This result is complementary to previous studies showing an effect of Mre11 
on HSV-1 production and supports a model where the MRN complex aids the HSV-1 
lifecycle.  
Next, we tested whether Nbs1 homologs encoded by other non-human primate 
species would similarly enhance virus yields in these Nbs1-deficient cells. NBS-ILB1 
cells were transduced to stably express the Nbs1 homologs of different non-human 
primate species. The orangutan (purple bar) and rhesus macaque (cyan bar) Nbs1 also 
supported higher levels of HSV-1 production, although not to the extent of human Nbs1 
(Figure 4-4A). Surprisingly, the white-cheeked gibbon allele (green bar) exhibited 
minimal to no gains in virus production, with viral titers equaling that of the parental, 
Nbs1-deficient cell line. This differential effect on HSV-1 production was not attributed 
to Nbs1 expression levels (Figure 4-4B, inset).  
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Figure 4-3: Protein sequence alignment of human and white-cheeked gibbon Nbs1. 
A protein sequence alignment was generated using ClustalX. The FHA, BRCT1, and 
BRCT2 domains are shown in yellow, purple, and blue, respectively (104). Sites of 
phosphorylation are indicated in red. Blue open boxes highlight residues important for 
binding CtIP (105), red boxes are residues that mediate interaction with Mre11 (106), and 
grey boxes are amino acids involved in ATM binding (107). 
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Figure 4-4: Primate orthologs of Nbs1 enhance HSV-1 production to varying 
degrees. (A) NBS-ILB1 cells complemented with empty vector, human, white-cheeked 
gibbon (WCG), orangutan, or rhesus macaque Nbs1 were infected with the in1863 HSV-
1 strain at an MOI of 0.01. Virus in the supernatant was harvested at 24 hours post 
infection and titered on Vero cells. The resulting plaques were counted (inset) and viral 
titers were calculated. Results shown are an average of three independent replicates with 
error bars representing standard deviations. (B) Complemented NBS-ILB1 cells were 
harvested and Western blot analysis was conducted to determine the expression level of 
Nbs1 in each of the cell lines. Actin was used as a loading control. Δ – empty vector, H – 
human, W – white-cheeked gibbon, O – orangutan, R – rhesus macaque. 
To explore this further, the ΔNBS1, human, and white-cheeked gibbon Nbs1 
complemented cell lines were infected at MOI 0.01 and progeny viruses were collected at 
12, 24, 36, and 48 hours post infection (Figure 4-5A). The measured viral yields from 
cells expressing human Nbs1 was consistently elevated at 24, 36, and 48 hours when 
compared to titers produced in the parental cell line (ΔNBS1), up to 37 fold higher at 24 
hours post infection. Interestingly, the viral titers from white-cheeked gibbon Nbs1 
expressing cells were essentially identical to that of the ΔNBS1 cell line at all timepoints 
analyzed. Collectively, these results indicate that only a small number of amino acids in 
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Nbs1 dictate the extent to which Nbs1 can augment HSV-1 production. Human and 
white-cheeked gibbon NbS1 differ by only 21 amino acids (Figure 4-2A), yet human 
Nbs1 supports virus infection, while white-cheeked gibbon Nbs1 has a phenotype 
equivalent to the Nbs1-deficient parental line  (Figure 4-5A). This is despite the fact 
both of these homologs are wildtype alleles, presumably supporting full DNA repair 
capabilities within their respective species. 
 
 
Figure 4-5: HSV-1 DNA replication is affected by Nbs1. (A) NBS-ILB1 cells 
complemented with empty vector, human, or white-cheeked gibbon Nbs1 were infected 
with the in1863 HSV-1 strain at an MOI of 0.01. Supernatant containing newly produced 
viruses were collected at 12, 24, 36, and 48 hours post infection and viral titers were 
determined by plaque assay on Vero cells. Results are presented as an average of three 
replicates with error bars representing standard deviations. (B) Infected cells in A were 
collected and DNA was extracted. The amount of viral DNA present in each of the 
samples was determined by qPCR with ICP27 primers and normalized to the endogenous 
control gene RPLP0. The amount of viral DNA is expressed as a fold increase relative to 
the 4 hour timepoint (input) and error bars represent standard error. 
The MRN complex is thought to be important for assisting in the replication of 
the DNA genome of HSV-1 (65). To determine if this surprising effect on virus 
production was consistent with this model, DNA was extracted from cells at several 
timepoints after infection (cells from Figure 4-5A) and viral DNA was quantified by 
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qPCR. As shown in Figure 4-5B, human Nbs1 supported viral DNA replication to a 
greater extent than the white-cheeked gibbon Nbs1 or the empty vector at 12, 24, and 36 
hours post infection. However, at 48 hours, all cells had approximately equal amounts of 
viral DNA present. In summary, we have shown a species-specific ability of wildtype 
Nbs1 orthologs to support the replication of human HSV-1. 
 
DNA repair functions of the white-cheeked gibbon Nbs1 are intact in human cells 
The protein sequences of human and white-cheeked gibbon Nbs1 differ at only 21 
amino acid positions. As mentioned previously, there is a paucity of amino acid changes 
in regions that are known to be important for function, such as the Mre11 binding 
domain, ATM binding region, and those that mediate CtIP binding (Figure 4-3). 
Nonetheless, to exclude the possibility that the white-cheeked gibbon Nbs1 is 
nonfunctional in human cells, we carried out a number of experiments.  
First, co-immunoprecipitation was performed to test the interaction of white-
cheeked gibbon Nbs1 with human Mre11 and Rad50. Both the human and white-cheeked 
gibbon Nbs1 were able to interact with human Mre11 and Rad50 in proportion to Nbs1 
expression levels (Figure 4-6). In contrast, no Nbs1 was detected in ΔNBS1 cells and 
consequently, Mre11 and Rad50 could not be detected in the immunoprecipitated 
samples.  
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Figure 4-6: Formation of the MRN complex is conserved. NBS-ILB1 cells 
complemented with the indicated NBS1 allele or empty vector (Δ) were lysed and 
immunoprecipitated using an Nbs1 antibody. The ability of human (H) and white-
cheeked gibbon (W) Nbs1 to form a complex with human Mre11 and Rad50 was 
assessed by immunoblotting.  
Next, we tested the integrity of DNA repair in each of these cell lines by 
measuring sensitivity to three different types of genotoxic stress: camptothecin, ionizing 
radiation, and hydroxyurea. Decreased cell viability is characteristic of hypersensitivity to 
a particular DNA damaging agent and can be assessed by a colony formation assay. 
When exposed to increasing levels of camptothecin or X-ray irradiation, both the human 
and white-cheeked gibbon Nbs1 were able to complement the deficiency in DNA repair 
activity when compared to cells that do not express Nbs1 (Figure 4-7A and 4-7B, 
respectively). No significant differences between any of the three cell lines were 
observed when hydroxyurea was used, although survival of cells expressing the white-
cheeked gibbon or human Nbs1 was slightly higher than Nbs1-deficient cells (Figure 4-
7C). Collectively, these data suggest that the functionality of the white-cheeked gibbon 
Nbs1 is preserved in human cells, and that the inability to increase HSV-1 titers is not 
simply due to a defect in its DNA repair functions in the context of a human cell. 	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Figure 4-7: DNA repair activity of Nbs1 is conserved among primates. NBS-ILB1 
cells expressing the empty vector, human, or white-cheeked gibbon Nbs1 were exposed 
to increasing doses of (A) camptothecin, (B) X-rays, and (C) hydroxyurea. Colony 
formation was assessed after 7-10 days. Percent survival was calculated by normalizing 
the number of colonies to untreated controls. Experiments were performed in triplicate 
and error bars represent standard deviations from the mean.  
 
Nbs1 does not affect the lifecycle of adenovirus and influenza 
Because the 21 amino acid differences between human and white-cheeked gibbon 
Nbs1 specifically affect HSV-1 replication and not the housekeeping functions of Nbs1 in 
the cell, we wanted to next test whether the replication of other viruses that gain nuclear 
access could be affected. Adenovirus is another DNA virus that replicates in the nucleus 
and has been shown to extensively interact with DNA repair machinery.  Specifically, 
the MRN complex orchestrates the concatenation of newly synthesized adenoviral 
genomes, thus preventing further DNA replication and packaging into viral particles (64). 
In turn, adenovirus encodes proteins that counteract the antiviral effects of the host MRN 
complex. The viral E4orf3 protein mislocalizes the MRN complex into nuclear tracks and 
aggresomes (64, 108-111), while the E4orf6/E1b55k complex is responsible for 
degrading MRN and other DNA repair constituents (64, 112-114).   
To determine if the different Nbs1 proteins were susceptible to degradation by 
adenoviral proteins, we infected our stably complemented cell lines with recombinant 
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adenoviral vectors encoding the Ad5 E4orf6 and E1b55k proteins (Figure 4-8A). Both 
the human and white-cheeked gibbon Nbs1 were degraded in the presence of the 
E4orf6/E1b55k complex, along with other known cellular targets such as Rad50 and p53. 
Degradation of the MRN complex inhibits concatemer formation, and therefore virus 
production was not expected to differ among the cell lines. Indeed, when cells were 
infected with wild-type Ad5, no differences in viral yield were observed at 24 and 48 
hours post infection (Figure 4-8B). Thus, the species-specific differences seen in Nbs1 do 
not have an impact on adenoviral infection and production.  
 
 
Figure 4-8: Sequence variation in Nbs1 does not affect the adenoviral lifecycle. (A) 
NBS-ILB1 cells expressing empty vector, human, or white-cheeked gibbon Nbs1 were 
infected with recombinant adenoviral vectors encoding the adenoviral E1b55k and 
E4orf6 proteins. Cells were harvested 96 hours post infection to detect degradation of the 
Nbs1 and other proteins targeted by the viral complex. Experiment performed by Neha 
Pancholi. (B) Cells were infected with wild-type adenovirus in triplicate. 24 and 48 hours 
post-infection, supernatants were collected and titered on HEK-293 cells. The results are 
expressed as an average of three replicates and error bars represent standard deviations. 
As mentioned above, in the absence of the viral E4 genes, the host MRN complex 
mediates the concatenation of adenoviral genomes and hinders viral genome replication. 
We were interested to see if both the human and white-cheeked gibbon Nbs1 proteins 
were equally capable of recognizing foreign adenoviral DNA and mounting this unique 
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host defense mechanism. We next infected our stably complemented cell lines with a 
mutant adenovirus lacking the E4 coding region (dl1004 Ad5). In cells expressing human 
Nbs1, a 10 fold decrease in the amount of viral DNA was apparent when compared to 
cells deficient in Nbs1 (Figure 4-9). Viral DNA replication was also reduced to the same 
extent in the presence of white-cheeked gibbon Nbs1. Collectively, these results show 
that both Nbs1 orthologs equally recognize actively replicating adenoviral genomes and 
are equally susceptible to the anti-MRN antagonists encoded by the virus.   
 
 
Figure 4-9: Human and white-cheeked gibbon Nbs1 are antiviral in the absence of 
the viral E4 genes. (A) NBS cells were infected with an E4-deleted adenovirus 5. After 4 
and 30 hours post-infection, cells were harvested and DNA was extracted. qPCR was 
performed using primers that amplify the adenoviral DBP gene and normalized to the 
endogenous tubulin control gene. These values were then expressed relative to the 4 hour 
input sample to obtain the values shown. The results are expressed as an average of three 
biological replicates and error bars represent standard deviations. Experiment performed 
by Neha Pancholi. 
Influenza virus also gains access to the nucleus during its lifecycle. Replication of 
this RNA virus does not involve DNA intermediates and DNA repair responses are not 
expected to have an effect on influenza infection. First, the complemented cells were 
infected with the Udorn H3N2 influenza strain at MOI 2 and cell lysates were collected at 
12 hours post infection (Figure 4-10A). Expression of the viral proteins hemagglutinin, 
 72 
nucleoprotein, and matrix were consistent across all cell lines tested, indicating that flu 
protein production is not affected by Nbs1. In addition, we were not able to discern any 
differences in the kinetics of virus production between the cell lines at several timepoints 
post infection (Figure 4-10B). Collectively, these data show that Nbs1 does not play a 
role in the influenza lifecycle and further supports our conclusion that species-specific 
differences in Nbs1 specifically affect HSV-1 and not general cell function or interactions 
with other viruses. 
 
 
Figure 4-10: Sequence variation in Nbs1 does not affect the influenza lifecycle. (A) 
Cells were infected with the A/Udorn/H3N2 influenza A virus at an MOI of 2. At 12 
hours post infection, cells were harvested and lysates were subjected to western blotting. 
Influenza proteins were visualized using an anti-Udorn antibody that recognizes 
hemagluttinin (HA), nucleoprotein (NP), and matrix (M). Nbs1 and actin expression 
levels were also determined.  (B) Cells were infected with influenza as described in A. 
Supernatants were collected at 1, 12, 24, and 48 hours post infection and titers were 
determined by plaque assay on MDCK cells.  
 
Interaction between ICP0 and Nbs1 is species-specific 
In the absence of Mre11, an ICP0 null HSV-1 strain displays severely crippled 
replication kinetics when compared to Mre11 complemented cells (65). The difference in 
virus yield between complemented and deficient cells is similar to wild-type virus 
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kinetics. This suggests that Mre11’s involvement in the HSV-1 lifecycle is independent 
of ICP0 functions. Furthermore, an ICP0 peptide fragment has been shown to bind 
human Nbs1 but not Mre11 (97), potentially signifying that Nbs1 may participate in 
HSV-1 replication in a manner that is complementary but independent of Mre11.  
First, we set out to determine the viral growth kinetics of the ICP0 null virus in 
our Nbs1 complemented cell lines. Unlike the patterns seen with the wild-type virus, the 
presence of human Nbs1 only increased virus titers about 3 fold at 36 and 48 hours post 
infection (Figure 4-11A). By 60 hours, no discernable differences in virus production 
were seen between the Nbs1 deficient and human Nbs1 complemented cells. A virus with 
a deletion in RING domain of ICP0 displayed growth kinetics similar to wild-type HSV-
1, indicating that ICP0 E3 ubiquitin ligase activity is not responsible for the ability of 
HSV-1 to hijack human Nbs1 function (Figure 4-11B). Unlike the previous reported 
effect of Mre11 on ICP0 null virus titers, our data indicate that a yet unidentified 
interaction could exist between ICP0 and human Nbs1.  
As mentioned previously, a peptide fragment of ICP0 has been shown to interact 
with the human Nbs1 protein. We next wished to recapitulate this interaction between 
full-length ICP0 and human Nbs1 and also to determine if the white-cheeked gibbon 
protein was capable of interacting with ICP0. 293Ts were transfected with plasmids 
encoding ICP0-GFP and FLAG-tagged human Nbs1 or white-cheeked gibbon Nbs1. 
ICP0-GFP was immunoprecipitated with a GFP antibody followed by immunoblotting 
with an anti-FLAG and anti-GFP antibody. As shown in Figure 4-12, we were able to 
confirm that human Nbs1 did indeed interact with ICP0 (lane 2). Conversely, we were 
surprised to see a lack of interaction between white-cheeked gibbon Nbs1 and ICP0 (lane 
4), a finding that strongly correlates to the decreased viral production phenotype observed 
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above (Figure 4-5A). In all cases, no detectable Nbs1 was precipitated in the absence of 
ICP0 (lanes 1 and 3). 
 
 
Figure 4-11: Nbs1 potentially interacts with ICP0. NBS cells expressing the empty 
vector, human, or white-cheeked gibbon Nbs1 were infected with a virus containing a 
deletion in the ICP0 coding regions (ΔICP0, A) or an ICP0 RING domain mutant virus 
(FXE, B) at an MOI of 0.3. Supernatants were collected at 24, 36, 48, and 60 hours post 
infection. Viruses were titered U2OS cells. The titers shown are an average of three 
independent replicates, with error bars representing standard deviations. 
 
 
Figure 4-12: Nbs1 interacts with ICP0 in a species-specific manner. HEK-293T cells 
were transfected with the indicated plasmids. Immunoprecipitation was performed using 
an anti-GFP antibody to precipitate ICP0-GFP and immunoblotting was performed to 
detect Nbs1 binding. Experiment performed by Eui Tae Kim. 
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To further determine if this lack of interaction correlated with viral titers, we 
examined the ability of Nbs1 from a closely related gibbon species to bind ICP0. The 
Nbs1 protein of siamang differs from the white-cheeked gibbon variant by only 12 amino 
acids. However, siamang Nbs1 expression greatly enhances virus yield in a manner 
similar to the human protein (Figure 4-13) and is able to co-precipitate with ICP0 (Figure 
4-12), further supporting our findings. This data, in combination with the wild-type virus 
production results, implies that ICP0 may bind and recruit human and siamang Nbs1, but 
not the white-cheeked gibbon Nbs1 protein, for efficient virus replication. Therefore, 
species-specific differences in Nbs1 may be an important determinant for maximal HSV-
1 infection. 
 
Figure 4-13: Siamang Nbs1 supports HSV-1 replication in a manner similar to 
human Nbs1. NBS-ILB1 cells complemented with human or siamang Nbs1 were 
infected with HSV-1 at an MOI of 0.01. Supernatant was collected at 12, 24, 36, and 48 
hours post-infection and titered on Veros. The results shown are an average of three 
replicates with error bars representing standard deviations. 
 
Specific residues in Nbs1 are important for HSV-1 replication 
Siamangs and white-cheeked gibbons are lesser apes that are separated by six to 
seven million years of divergence (115). As mentioned above, only 12 out of the 754 
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residues differ between the Nbs1s encoded by these two species, most of which are 
concentrated towards the C-terminus of the protein. To determine if specific amino acids 
in Nbs1 are responsible for the differences in supporting HSV-1 replication, we replaced 
four amino acids in the white-cheeked gibbon Nbs1 with the residues from the siamang 
Nbs1 (Figure 4-14A, WS-1). The corresponding mutations were also made in the 
siamang allele (SW-2). We then generated stable cell lines expressing these constructs 
and infected them with HSV-1. Much to our surprise, WS-1 supported HSV-1 replication 
to the same degree as the siamang Nbs1 while SW-2 levels of virus production mirrored 
that of white-cheeked gibbon Nbs1 (Figure 4-14B). This result indicates that just four 
amino acids in Nbs1 (residues 603, 624, 631, and 673) are responsible for the large 
differences in virus titers produced in these cell lines. These differences were not 
attributable to a defect in DNA repair activity as assessed by camptothecin sensitivity 
(data not shown). 
 
 
Figure 4-14: Key residues in Nbs1 are responsible for differences in virus 
production. (A) Chimeric gibbon Nbs1 constructs generated for interaction assays. (B) 
NBS1 cells expressing the indicated Nbs1 constructs were infected with wild-type HSV-1 
at an MOI of 0.01. Viruses were harvested from the supernatant at 30 hours post infection 
and titered Veros. The results are an average of three independent replicates with error 
bars representing standard deviations from the mean. 
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DISCUSSION  
We present for the first time that a host protein that is neither a receptor nor an 
antiviral restriction factor, may act as a barrier to cross-species transmission of HSV-1. 
Although viral replication does occur to some extent in cells lacking Nbs1 and in the 
presence of white-cheeked gibbon Nbs1, it is dramatically crippled when compared to 
viral titers produced in human Nbs1 and other primate Nbs1 complemented cells (Figure 
4-5A). However, the MOIs used in this study are likely to be higher than naturally 
occurring HSV-1 infections, possibly pushing the balance towards active viral 
replication. Nonetheless, slower replication kinetics in the context of a whole organism 
could allow ample time for full activation of the immune response, potentially resulting 
in a profound impact on the virulence of a virus. In addition, non-permissive Nbs1 
variants and other host restriction factors could potentially work in concert to further 
restrict HSV-1 from actively replicating in infected cells. 
Our data clearly show that Nbs1 is co-opted by HSV-1 in a species-specific 
manner (Figure 4-4A). In particular, key residues in Nbs1 determine the degree to which 
this DNA repair protein can positively influence viral replication (Figure 4-14B). This 
effect is not due to differences in the intrinsic functions of the primate Nbs1 orthologs as 
assessed by sensitivity to genotoxic stress. This leaves the possibility that these residues 
mediate interaction with a viral protein that may recruit Nbs1 to enhance virus 
replication. It is intriguing that the ability of ICP0 to bind the different primate orthologs 
of Nbs1 differentially correlates to the drastic differences in virus production seen (Figure 
4-12). Furthermore, this interaction does not facilitate degradation of Nbs1, unlike other 
host factors known to interact with ICP0 (93, 94, 97, 116-118). However, the RING 
domain that mediates ubiquitination and degradation of other cellular substrates may be 
important in hijacking Nbs1 functions (Figure 4-11B). How Nbs1 specifically affects 
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HSV-1 replication, and whether or not ICP0 directly interacts with or ubiquitinates Nbs1 
is currently under investigation.  
Additionally, this study has further revealed additional information on how HSV-
1 hijacks the host DNA repair machinery to promote productive infection. Much like 
Mre11 (65), the presence of specific Nbs1 variants augment viral DNA replication and 
virus yield (Figure 4-5). At first glance, this is not surprising because Mre11 and Nbs1 
exist in a complex within the cell. However, key pieces of evidence suggest that the roles 
that Mre11 and Nbs1 play in the HSV-1 lifecycle may be complimentary, but separable. 
For example, a proteomic analysis has shown that Mre11 and Rad50, but not Nbs1, 
interact with the viral single-stranded DNA binding protein ICP8 (98). In another study, 
an ICP0 peptide fragment was able to co-precipitate with Nbs1, but not other components 
of the MRN complex (97). Furthermore, although replication of the ICP0-null virus in 
our Nbs1-deficient cells displays slightly impaired growth kinetics when compared to 
Nbs1 complemented cells (Figure 4-11A), the disparity in viral titers is nowhere near the 
differences seen in Mre11-deficient and Mre11 complemented cell lines (65). Further 
studies are warranted to better understand the dynamic interactions between individual 
MRN components and HSV-1 proteins. 
 
CONCLUSIONS 
New diseases, including new human diseases, emerge when viruses evolve 
compatibility with a novel host species. For this reason, it is critical to define the host 
components that dictate viral host range. Here, we show that compatibility with a DNA 
repair factor, Nbs1, is a critical determinant of cross-species transmission for herpes 
simplex virus 1 (HSV-1) in primates. We show that the viral ICP0 protein of HSV-1 
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interacts with human Nbs1, and that Nbs1 facilitates genome replication of this DNA 
virus. We show that the ICP0 interaction with Nbs1 is species-specific, and does not 
occur with all primate homologs of Nbs1. These results broaden our current 
understanding of the host determinants of cross-species transmission to include essential, 
nuclear proteins like Nbs1. 
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Chapter 5: Concluding Remarks 
 
REDUCING THE ERROR RATE OF HIGH-THROUGHPUT SEQUENCING 
In chapter 2, I present a novel library preparation method with an accompanying 
bioinformatics pipeline that reduces the error rate of high-throughput sequencing data, 
allowing for the acquisition of high quality, low error reads. Although high-throughput 
sequencing technologies have expanded and revolutionized a variety of scientific fields, 
the error rates associated with these technologies do not allow for accurate measurements 
of variation within heterogenous samples. In these cases, true genetic variation within a 
sample cannot be distinguished from sequencing errors and hinders the study of complex 
samples, such as viral populations and mutations arising from inaccurate DNA repair. As 
error rates of high-throughput sequencing technologies continue to improve, the error rate 
problem may become more approachable, even without error-correction methods. 
However, even if error rates can be substantially decreased without the use of library 
preparation schemes, our method and other competing methods can be adapted to allow 
for more accurate “counting” of unique molecules. 
Although we were able to achieve error rates that were equivalent to the gold 
standard of Sanger sequencing methods, there are additional modifications that are 
currently underway in order to further drive the error rates of our method down while still 
maintain high (or higher) efficiencies. Using the approach of the duplex barcoding 
method (7), we are developing a variation of our circle-sequencing method that utilizes 
the information from both strands of a duplex DNA molecule. Although mutations can 
occur at any step along the sample preparation process, they will do so at random along 
the length of the DNA molecule, and in most cases, do not occur in both bases of a 
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complementary base pair in the absence of DNA repair mechanisms. In fact, our lab 
already has evidence to suggest that this new approach does indeed reduce the error rate 
much more dramatically than duplex barcoding methods. Harnessing the strengths of 
duplex barcoding and circle sequencing into one method may drive the error rates down 
even further without sacrificing efficiency. 
 
POSITIVE SELECTION IN BRCA1 AND BRCA2 
In chapter 3, I describe the unique evolutionary trajectory seen in BRCA1 and 
BRCA2. Specific residues have been identified to be rapidly evolving in response to a 
strong selective pressure that is yet to be uncovered. Our dataset, which is comprised of a 
large number of very closely primate species, shows that selection is acting upon humans 
and our closest living relatives. This allows us to speculate that a selective pressure 
specific to primates is driving the rapid evolution seen in both BRCA1 and BRCA2. 
Unlike the large datasets used by previous groups, which included widely divergent 
mammal species, our dataset allows us to show that these evolutionary signatures are 
strong enough to detect with high confidence within closely related species and that 
specific selective pressures may be at play within these species. One can imagine that 
BRCA1 and BRCA2 may also be involved in host-virus interactions, much like the story 
of Nbs1 and ICP0. Many of the known functions of BRCA1, which include a role in 
transcription, DNA repair, cell cycle regulation, and centrosome maintenance, could 
feasibly play a role in viral lifecycles.  
Interestingly, there is increasing evidence to suggest that BRCA1 plays a critical 
role in the developing brain (119). Conditional knockout of BRCA1 in mice results in 
high levels of apoptosis and an abnormally small brain size. In addition, expression of 
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BRCA1 is regulated by microcephalin, a protein involved in DNA repair and cell cycle 
regulation (120). Mutations in the microcephalin gene, MCPH1, result in a disorder 
characterized by a small head circumference and a decreased size of the brain. Based on 
these findings, it is possible that selection is acting upon BRCA1 functions that are 
critical during brain development. It will be interesting to see if the sites of positive 
selection we have identified have an effect on this important embryological process and if 
this effect correlates to the known brain masses of primate species used in our study. 
 
NBS1 AND HSV-1 
The cellular response to DNA damage is a highly coordinated and complex 
process. Several mechanisms exist to safeguard against the many types of lesions that can 
be incurred, ultimately resulting in the repair of damage, senescence, or apoptosis. One of 
the most deleterious types of DNA damage is the double-strand break, which is 
recognized by the Mre11-Rad50-Nbs1 (MRN complex) (121). ATM rapidly localizes to 
sites of damage via interactions with MRN, leading to autophosphorylation and 
subsequent activation. Once activated, ATM mediates the phosphorylation of several 
other repair factors such as H2AX, MDC1, and Nbs1, resulting in the retention of these 
proteins at the break. Recruitment of the E3 ubiquitin ligases, RNF8 and RNF168, to the 
sites of damage results in several additional post-translation modification events that 
ultimately leads to the accumulation of repair factors and chromatin remodeling near the 
sites of damage. Additionally, it has become increasingly evident that viruses that 
replicate within the nucleus activate these same pathways and can be considered as yet 
another form of genotoxic stress. In chapter 4, I describe a way in which HSV-1 has 
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evolved to utilize the functions of the DNA repair protein, Nbs1, to enhance the viral 
lifecycle. 
When HSV-1 enters the cell, the intact capsid core travels to the nucleus where it 
docks onto the nuclear pore complex. The ~150 kb genome is confined within a relatively 
small 125 nm icosahedral shell, resulting in the ejection of viral contents into the nucleus 
through a pressure-driven mechanism (122). Incoming viral genomes rapidly co-localize 
with DNA repair factors such as γH2AX and MDC1 at sites of viral entry (68). In fact, 
many of these host factors are the same proteins that mark sites of double-strand breaks 
in host chromosomal DNA. In the absence of the virally encoded ICP0 protein, the 
recruitment of RNF8 and RNF168 results in the deposition of repressive marks onto the 
viral genome that suppress viral transcription. In order to subvert this defense strategy 
employed by the host, the ICP0 protein of HSV-1 ubiquitinates and degrades the antiviral 
effects mediated by RNF8 and RNF168 (94). Therefore, the DNA damage response 
during HSV-1 entry into the nucleus can be viewed as an intrinsic defense mechanism 
against viral infection. 
However, other components of the ATM signaling pathway have been shown to 
greatly enhance the viral lifecycle. For example, Mre11- and ATM-deficient cells exhibit 
much lower yields in virus production (65, 91). In addition, phosphorylation of the 
checkpoint kinase, chk2, by ATM is required for inducing G2/M arrest for maximal viral 
replication (92). Collectively, this suggests that HSV-1 may be inducing the ATM 
signaling pathway in order to induce cell cycle arrest, while inhibiting the aspect of ATM 
signaling that results in transcriptional repression of viral genomes. However, initial 
activation event leading to ATM signaling is still unknown.  
In our study, we show that human Nbs1 also enhances the viral lifecycle, much 
like the previously reported effect of Mre11, ATM, and chk2. In addition, we identify a 
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naturally occurring Nbs1 variant from a non-human primate that is not susceptible to 
hijacking by the virus. We show that variants of Nbs1 that support HSV-1 replication 
interact with ICP0, while those that do not enhance virus production are not able to 
associate with ICP0 (data not shown).  
The results from our study suggest that the successful interaction between Nbs1 
and ICP0 results in the ubiquitination of Nbs1 and this may be the reason why Nbs1 
exerts a positive effect on virus replication. However, how these events specifically 
contribute to the HSV-1 lifecycle is still undetermined. Interestingly, Nbs1 has been 
shown to be ubiquitinated by the cellular E3 ubiquitin ligase skp2 in response to DNA 
damage, allowing for the binding and activation of ATM (123). One can imagine that 
ubiquitination of Nbs1 by ICP0 could be mimicking this cellular process, resulting in the 
activation of the DNA damage response. In fact, expression of ICP0 alone has been 
demonstrated to induce autophosphorylation and activation of ATM (92). If this were 
true, then Nbs1 may be the first contact point in which ICP0 activates the ATM pathway. 
To our knowledge, this is the first time in which a model has been presented that 
specifically addresses how the ATM pathway is initially activated during the early stages 
of the HSV-1 lifecycle. This model can also explain why some interactions between ICP0 
and DNA repair factors or checkpoint regulators do not result in degradation of the host 
proteins and ascribes a new function for ICP0 in both activating and disarming certain 
aspects of this major signaling pathway. Additional experiments are currently underway 
to test whether this is indeed the case. It will be interesting to see if there are any 
differences in ATM activation between our cell lines during infection with the wild-type 
and ICP0-null viruses.  
In addition to the mechanistic insights we have uncovered in our study of the 
HSV-1 lifecycle, we show that ICP0 interacts with Nbs1 in a species-specific manner and 
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that this interaction correlates strongly to an increase in viral titers. Using naturally 
occurring primate alleles, we identified four residues critical for this interaction. We also 
show for the first time that a protein that is neither a restriction factor or a cellular entry 
receptor may act as a barrier to cross-species transmission of HSV-1 and that the ability 
of specific primate Nbs1 variants to evade interaction with ICP0 limits viral replication. 
This phenomenon may be a result of long-term coevolution between primate hosts and 
their cognate herpes simplex viruses. In this scenario, the ICP0 of a specific herpes 
simplex virus may have evolved the ability to interact with the Nbs1 of its primate host in 
order to utilize its functions for the advancing the viral lifecycle. However, when this 
ICP0 variant encounters a new Nbs1 from a non-host species, subtle sequence differences 
within the ICP0 binding region of Nbs1 may alter the ability of this particular ICP0 
variant to establish an interaction. Moreover, this variability in Nbs1 of the non-host 
species may be a result of coevolution with the ICP0 of its own herpes simplex virus. It 
will be interesting to see if other ICP0 proteins encoded by primate herpes simplex 
viruses exhibit a different pattern of compatibility with primate Nbs1 proteins or whether 
this inability of the white-cheeked gibbon Nbs1 to evade ICP0 interaction is unique 
evolutionary accident. Attempts to experimentally evolve HSV-1 in cells expressing the 
white-cheeked gibbon Nbs1 were not successful, suggesting that the latter scenario may 
be the case. However, since HSV-1 is a considerably slow evolving virus, extensive serial 
passaging of the virus may be required. Nonetheless, we demonstrate the power in using 
primate alleles for mapping the interface of dynamic host-virus interactions. 
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Appendix A 
CIRCLE SEQUENCING BIOCHEMICAL PROTOCOL 
Materials: 
DNA of interest 
Tris-EDTA 
Low Molecular Weight Ladder (NEB N3233L) 
Low melting point agarose (NuSieve GTG Lonza 50081) 
TBE 
SYBR Gold (Invitrogen S-11494) 
QIAEX II Gel Extraction Kit (QIAGEN 20021) 
DNase-, RNase-free water 
T4 PNK (NEB M0201S) 
10 mM ATP (NEB P0756S) 
QIAGEN MinElute Purification Kit (QIAGEN 28004) 
Liquid nitrogen 
CircLigase II (Epicentre CL9025K) 
Exonuclease I (NEB M0293S) 
Exonuclease III (NEB M0206S) 
2X Annealing Buffer (10 mM Tris pH8, 50 mM NaCl, 1 mM EDTA) 
Exo-Resistant Random Primers (Thermo SO181) 
Phi29 DNA Polymerase (NEB M0269L) 
10 mM dNTP (NEB N0447L) 
Inorganic Pyrophosphatase (NEB M0361S) 
Uracil-DNA Glycosylase (NEB M0280S) 
Formamidopyrimidine-DNA Glycosylase  (NEB M0240S) 
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3M Sodium Acetate pH 5.2 
100% Ethanol 
70% Ethanol 
MiSeq library preparation kit 
Ampure XP beads (Agencourt A63880) 
Magnetic stand 
KAPA HiFi DNA polymerase (KAPA Biosystems KK2101) 
Covaris S220 
Microtubes for shearing 
Nanodrop 
Thermocycler or water bath 
Heat block 
MiSeq 
 
Procedure: 
A. DNA shearing (Begin here if sequencing genomic DNA) 
1. Shear gDNA resuspended in TE to 150 bp using Covaris S220. Shear about 10 
µg at a time in 130 µl total volume.  
Duty cycle – 10% 
Intensity – 5  
Cycles per burst – 200  
Time – 14 min  
Note: Shearing conditions will vary depending on machine. Also, it is 
important that the DNA be resuspended in TE. DNA in H2O gives a broader 
length distribution for unknown reasons. Also, use Invitrogen’s DNA quant 
 88 
machine to quantitate yeast DNA preps. We have noticed that contaminants in 
the prep give inaccurate readings on the spec. Run 10 µl of sheared product 
out on a 1.5% gel to determine if shearing was efficient. If needed, combine 
tubes and use Speedvac to concentrate.  
2. Run at least 2.5 µg of sheared DNA in 1 lane and a low MW DNA ladder in a 
separate lane of a 1.5% low melting point agarose gel in 1X TBE. Cut off the 
lane with the DNA ladder and stain with SYBR Gold (1:10,000 dilution in 
TBE). Place next to the unstained remainder of the gel. Use that placement as 
a guide to cut 150 bp fragments from the sheared gDNA sample lane.  
Optional: Stain the unused portion of the gel to see if right size fragments 
were cut from the gel. It is advisable to also cut slices slightly higher (175 bp, 
200 bp, 250 bp) and run these fragments on a Bioanalyzer to ensure that 
fragment size is centered around 150 bp. 
Note: The average size of the fragments is important.  They should be 
slightly less than 1/3 of the average read length of the sequencing technology 
that you are using. This will ensure that you get at least 3 repeats of your 
sequence in 1 read length. 
3. Gel extract the excised portion of material using the QIAEX II Gel Extraction 
Kit. Determine concentration using nanodrop. 
 
B. DNA modification and preparation (Begin here if sequencing amplicons) 
4. Phosphorylate the gel extracted fragments using T4 PNK. 
5 µl   10X T4 PNK buffer 
5 µl   10 mM ATP 
< 300 pmol sheared DNA 
 89 
to 49 µl H2O 
1 µl   T4 PNK (10U) 
Incubate at 37oC for 30 min. 
5. Purify DNA using QIAGEN MinElute Purification Kit. Elute in 20 µl of H2O. 
Note: This kit claims to purify PCR products 70 bp to 4 kb 
6. Denature DNA by incubating at 95oC for 15 min, preferably in a heat block. 
Immediately remove from heat block and snap freeze in liquid nitrogen for 5 
min. Place frozen sample on ice and allow to melt slowly. 
Note: This is a critical step in which single-stranded DNA is generated for the 
circularization reaction. Freezing in liquid nitrogen ensures that rapid cooling 
occurs, preventing reannealing of DNA into double-stranded fragments. 
7. Determine concentration of DNA using nanodrop. Make sure to use ssDNA 
settings when determining concentration. 
 
C. Circularization 
8. Set up circularization reactions. 
2 µl   CircLigase II 10X Reaction Buffer 
1 µl   50 mM MnCl2 
5 pmol  ssDNA (~240 ng for 150 bases) 
to 19 µl  H2O 
1 µl   CircLigase II ssDNA Ligase (100U) 
Incubate at 60oC for 1-16 hours. 
Note: It is convenient to set up this reaction at the end of the day and let it go 
overnight. 
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9. Perform a 2nd round of circularization by adding 1 µl of CircLigase II to the 
reaction and incubating at 60oC for an additional 6 hours. Heat inactivate the 
enzyme at 80oC for 10 min. 
Note: The addition of more enzyme is not necessary but can increase the 
overall yield of circularized product in some instances. 
10. Digest any linear DNA fragments still remaining in the reaction by adding 1 
µl Exonuclease I (20U) and 0.5 µl Exonuclease III (50U). Incubate at 37oC for 
1 hour and heat inactivate at 80oC for 10 min.  
11. Purify the circularized products using QIAGEN MinElute clean up kit and 
elute in 20 µl H2O. Determine concentration using ssDNA settings. 
Note: You should recover about 10-20% of your input DNA.  
 
D. Rolling Circle Amplification (RCA) 
12. Anneal random primers to DNA circles. 
10 µl   2X Annealing Buffer  
(10 mM Tris pH8, 50 mM NaCl, 1 mM EDTA) 
1 µl   Exo-Resistant Random Primers  
1-100 ng  circularized DNA 
to 20 µl H2O 
Incubate at 95oC for 5 min and cool to 4oC. 
Note: This step is performed in a thermocycler. The ramp rate of cooling is 
not crucial for primer annealing. 
13. Set up RCA reaction on ice. 
5 µl   10X Phi29 DNA Polymerase Reaction Buffer 
1 µl   100X BSA 
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1 µl   10 mM dNTP 
20 µl   primer-annealed circularized DNA 
17 µl   H2O 
1 µl    Inorganic Pyrophosphatase (0.2 U) 
1 µl   Uracil-DNA Glycosylase (10U) 
1 µl   Formamidopyrimidine-DNA Glycosylase  (16U)  
2 µl   phi29 DNA Polymerase 
Incubate at 30oC for 3 hours. Heat inactivate at 65oC for 10 min.  
Note: Two modifications have been made to the traditional Phi29 reaction. 
Addition of Uracil-DNA Glycosylase removes any deaminated cytosines from 
DNA. Formamidopyrimidine-DNA Glycosylase is also added to remove 8-
oxo-guanine products. Both of these types of damaged bases will result in 
errors in the DNA sequence in downstream processes.  
Note: If less than 10 ng of circles are used in for RCA, longer amplification 
times (more than 3 hours) may be required to obtain sufficient amounts of 
product for library preparation. 
14. Purify RCA products by ethanol precipitation. Resuspend DNA in TE. 
 
E. Library preparation for NGS  
Note: The remainder of the protocol just describes standard Illumina MiSeq 
library preparation. The only modifications to the manufacturer-recommended 
protocol involve the shearing of RCA products and the purification of final library 
preps. The following protocol produces libraries for MiSeq 2x250 reads. 
Sample preparation: 
15. Shear RCA products to 1,500 bp using Covaris S220. 
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Duty cycle – 2% 
Intensity – 4   
Cycles per burst – 200  
Time – 15 sec 
16. Purify DNA using MinElute Purification Kit. Elute in 20 µl H2O. 
17. Prepare adaptor ligations as suggested by manufacturer. (EX. TruSeq) 
18. Size select adaptor-ligated samples using Ampure XP beads. 
Bring Ampure XP beads to room temperature (about 30 min). 
Add 0.6X volume of beads to sample and vortex for 1 min. Spin briefly. 
Incubate at room temperature for 15 min. 
Magnetize sample for 5 min. 
Remove supernatant and discard. 
Wash with fresh 70% ethanol two times. 
Dry beads for 5 min. 
Add 70 µl of TE to beads and vortex for 1 min. Spin briefly and incubate 
at room temperature for 5 min. 
Magnetize sample for 5 min. 
Remove supernatant and place in new tube. 
19. Set up PCRs to amplify library. 
10 µl   5X HiFi Buffer 
1.5 µl   10 mM dNTP 
1.5 µl   10 uM P5 PCR primer 
1.5 µl   10 uM P7 PCR primer 
34.5 µl  DNA 
1 µl   KAPA HiFi 
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95oC 2 min 
  98C 20 sec 
60C 15 sec 10 cycles 
72oC 2 min 
72oC  5 min 
4oC  hold 
20. Size select PCR products using 0.6X volume Ampure XP beads (Step 18). 
Alternatively, gel extract 1.2 kb fragments with 1% low melting point agarose 
gel using QIAEX II kit. 
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